#gid	GOTERM_BP_FAT	GOTERM_CC_FAT	GOTERM_MF_FAT	INTERPRO	KEGG_PATHWAY
ELOVL6	GO:0046394~carboxylic acid biosynthetic process;GO:0016053~organic acid biosynthetic process	NA	NA	NA	NA
CEBPD	NA	NA	GO:0046983~protein dimerization activity;GO:0003700~transcription factor activity;GO:0043565~sequence-specific DNA binding	IPR004827:Basic-leucine zipper (bZIP) transcription factor	NA
KRT16	GO:0007010~cytoskeleton organization;GO:0008283~cell proliferation	NA	NA	NA	NA
MMP2	GO:0060325~face morphogenesis;GO:0044236~multicellular organismal metabolic process;GO:0060323~head morphogenesis;GO:0048705~skeletal system morphogenesis;GO:0001944~vasculature development;GO:0001666~response to hypoxia;GO:0001501~skeletal system development;GO:0032963~collagen metabolic process;GO:0060324~face development;GO:0070482~response to oxygen levels;GO:0001568~blood vessel development	GO:0005886~plasma membrane;GO:0005615~extracellular space;GO:0031012~extracellular matrix;GO:0005578~proteinaceous extracellular matrix;GO:0005576~extracellular region;GO:0044421~extracellular region part;GO:0030016~myofibril	GO:0005509~calcium ion binding	IPR006025:Peptidase M, neutral zinc metallopeptidases, zinc-binding site;IPR001818:Peptidase M10A and M12B, matrixin and adamalysin	NA
SH3PXD2B	GO:0045597~positive regulation of cell differentiation;GO:0051094~positive regulation of developmental process	NA	NA	NA	NA
WNT2	GO:0010033~response to organic substance;GO:0007010~cytoskeleton organization;GO:0043627~response to estrogen stimulus;GO:0048545~response to steroid hormone stimulus;GO:0051674~localization of cell;GO:0043254~regulation of protein complex assembly;GO:0006928~cell motion;GO:0051258~protein polymerization;GO:0048870~cell motility;GO:0008015~blood circulation;GO:0009725~response to hormone stimulus;GO:0016477~cell migration;GO:0042493~response to drug;GO:0003013~circulatory system process;GO:0008285~negative regulation of cell proliferation;GO:0009719~response to endogenous stimulus;GO:0042127~regulation of cell proliferation;GO:0032271~regulation of protein polymerization;GO:0032273~positive regulation of protein polymerization	GO:0031982~vesicle;GO:0031012~extracellular matrix;GO:0031410~cytoplasmic vesicle;GO:0045121~membrane raft;GO:0044433~cytoplasmic vesicle part;GO:0031988~membrane-bounded vesicle;GO:0005578~proteinaceous extracellular matrix;GO:0005576~extracellular region;GO:0016323~basolateral plasma membrane;GO:0044459~plasma membrane part;GO:0005886~plasma membrane;GO:0044421~extracellular region part;GO:0005625~soluble fraction;GO:0016023~cytoplasmic membrane-bounded vesicle	NA	NA	NA
ADAMTS4	GO:0001501~skeletal system development	GO:0005615~extracellular space;GO:0031012~extracellular matrix;GO:0005578~proteinaceous extracellular matrix;GO:0005576~extracellular region;GO:0044421~extracellular region part	NA	IPR010294:ADAM-TS Spacer 1;IPR006025:Peptidase M, neutral zinc metallopeptidases, zinc-binding site;IPR013273:Peptidase M12B, ADAM-TS;IPR000884:Thrombospondin, type 1 repeat	NA
NFIL3	GO:0048511~rhythmic process;GO:0006955~immune response	NA	GO:0046983~protein dimerization activity;GO:0003700~transcription factor activity;GO:0043565~sequence-specific DNA binding	IPR004827:Basic-leucine zipper (bZIP) transcription factor	NA
GADD45A	GO:0045859~regulation of protein kinase activity;GO:0007010~cytoskeleton organization;GO:0051329~interphase of mitotic cell cycle;GO:0051348~negative regulation of transferase activity;GO:0022403~cell cycle phase;GO:0042325~regulation of phosphorylation;GO:0000079~regulation of cyclin-dependent protein kinase activity;GO:0006469~negative regulation of protein kinase activity;GO:0051174~regulation of phosphorus metabolic process;GO:0006915~apoptosis;GO:0051338~regulation of transferase activity;GO:0051325~interphase;GO:0033673~negative regulation of kinase activity;GO:0051726~regulation of cell cycle;GO:0012501~programmed cell death;GO:0019220~regulation of phosphate metabolic process;GO:0008219~cell death;GO:0016265~death;GO:0043549~regulation of kinase activity	NA	NA	NA	hsa04115:p53 signaling pathway;hsa04010:MAPK signaling pathway
RGCC	GO:0045859~regulation of protein kinase activity;GO:0051726~regulation of cell cycle;GO:0051174~regulation of phosphorus metabolic process;GO:0051338~regulation of transferase activity;GO:0043549~regulation of kinase activity;GO:0042325~regulation of phosphorylation;GO:0019220~regulation of phosphate metabolic process;GO:0000079~regulation of cyclin-dependent protein kinase activity	NA	NA	NA	NA
PTGES	GO:0006690~icosanoid metabolic process;GO:0008285~negative regulation of cell proliferation;GO:0042127~regulation of cell proliferation	NA	NA	NA	NA
FN1	GO:0008360~regulation of cell shape;GO:0007155~cell adhesion;GO:0022604~regulation of cell morphogenesis;GO:0009611~response to wounding;GO:0051674~localization of cell;GO:0006953~acute-phase response;GO:0016477~cell migration;GO:0006952~defense response;GO:0042060~wound healing;GO:0006928~cell motion;GO:0002526~acute inflammatory response;GO:0034329~cell junction assembly;GO:0022610~biological adhesion;GO:0006954~inflammatory response;GO:0048870~cell motility	GO:0031410~cytoplasmic vesicle;GO:0005578~proteinaceous extracellular matrix;GO:0005576~extracellular region;GO:0031091~platelet alpha granule;GO:0031983~vesicle lumen;GO:0005615~extracellular space;GO:0005886~plasma membrane;GO:0044421~extracellular region part;GO:0016023~cytoplasmic membrane-bounded vesicle;GO:0060205~cytoplasmic membrane-bounded vesicle lumen;GO:0031093~platelet alpha granule lumen;GO:0031012~extracellular matrix;GO:0030141~secretory granule;GO:0031982~vesicle;GO:0031988~membrane-bounded vesicle;GO:0044433~cytoplasmic vesicle part;GO:0044459~plasma membrane part	GO:0005518~collagen binding;GO:0030246~carbohydrate binding;GO:0005539~glycosaminoglycan binding;GO:0008201~heparin binding;GO:0030247~polysaccharide binding;GO:0001871~pattern binding	IPR013032:EGF-like region, conserved site;IPR016060:Complement control module;IPR008957:Fibronectin, type III-like fold;IPR003961:Fibronectin, type III	hsa04512:ECM-receptor interaction
RRP12	NA	GO:0005730~nucleolus	NA	NA	NA
PFKP	NA	GO:0005625~soluble fraction	GO:0030246~carbohydrate binding	NA	NA
ITGA5	GO:0007155~cell adhesion;GO:0009611~response to wounding;GO:0007157~heterophilic cell adhesion;GO:0051674~localization of cell;GO:0016477~cell migration;GO:0042060~wound healing;GO:0006928~cell motion;GO:0034329~cell junction assembly;GO:0048870~cell motility;GO:0022610~biological adhesion	GO:0005886~plasma membrane;GO:0031226~intrinsic to plasma membrane;GO:0005887~integral to plasma membrane;GO:0009986~cell surface;GO:0016323~basolateral plasma membrane;GO:0044459~plasma membrane part	GO:0032403~protein complex binding;GO:0005178~integrin binding;GO:0005509~calcium ion binding	NA	hsa04512:ECM-receptor interaction;hsa04640:Hematopoietic cell lineage
MYOC	NA	GO:0005615~extracellular space;GO:0005576~extracellular region;GO:0044421~extracellular region part	NA	NA	NA
PADI4	NA	NA	GO:0005509~calcium ion binding	NA	NA
ABL1	GO:0030029~actin filament-based process;GO:0007010~cytoskeleton organization;GO:0051329~interphase of mitotic cell cycle;GO:0022403~cell cycle phase;GO:0042981~regulation of apoptosis;GO:0008630~DNA damage response, signal transduction resulting in induction of apoptosis;GO:0043085~positive regulation of catalytic activity;GO:0051325~interphase;GO:0043067~regulation of programmed cell death;GO:0043065~positive regulation of apoptosis;GO:0010942~positive regulation of cell death;GO:0051353~positive regulation of oxidoreductase activity;GO:0030036~actin cytoskeleton organization;GO:0007155~cell adhesion;GO:0008629~induction of apoptosis by intracellular signals;GO:0043068~positive regulation of programmed cell death;GO:0010941~regulation of cell death;GO:0044093~positive regulation of molecular function;GO:0022610~biological adhesion	GO:0005730~nucleolus	NA	NA	hsa05220:Chronic myeloid leukemia;hsa04012:ErbB signaling pathway
TPPP3	GO:0007010~cytoskeleton organization	NA	NA	NA	NA
BCL3	GO:0045944~positive regulation of transcription from RNA polymerase II promoter;GO:0009314~response to radiation;GO:0002443~leukocyte mediated immunity;GO:0002252~immune effector process;GO:0006955~immune response;GO:0042981~regulation of apoptosis;GO:0008630~DNA damage response, signal transduction resulting in induction of apoptosis;GO:0002250~adaptive immune response;GO:0001817~regulation of cytokine production;GO:0043065~positive regulation of apoptosis;GO:0043067~regulation of programmed cell death;GO:0008629~induction of apoptosis by intracellular signals;GO:0030198~extracellular matrix organization;GO:0043066~negative regulation of apoptosis;GO:0002285~lymphocyte activation during immune response;GO:0045727~positive regulation of translation;GO:0051240~positive regulation of multicellular organismal process;GO:0002286~T cell activation during immune response;GO:0009411~response to UV;GO:0060548~negative regulation of cell death;GO:0001819~positive regulation of cytokine production;GO:0043069~negative regulation of programmed cell death;GO:0002263~cell activation during immune response;GO:0006959~humoral immune response;GO:0006952~defense response;GO:0009617~response to bacterium;GO:0010942~positive regulation of cell death;GO:0009628~response to abiotic stimulus;GO:0002366~leukocyte activation during immune response;GO:0043068~positive regulation of programmed cell death;GO:0010941~regulation of cell death;GO:0043062~extracellular structure organization;GO:0002460~adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains	NA	GO:0003700~transcription factor activity	NA	NA
SERPINE1	GO:0007599~hemostasis;GO:0009611~response to wounding;GO:0048878~chemical homeostasis;GO:0050878~regulation of body fluid levels;GO:0031099~regeneration;GO:0045765~regulation of angiogenesis;GO:0042060~wound healing;GO:0042592~homeostatic process;GO:0032101~regulation of response to external stimulus;GO:0050817~coagulation;GO:0042127~regulation of cell proliferation;GO:0007596~blood coagulation	GO:0005886~plasma membrane;GO:0005625~soluble fraction;GO:0005576~extracellular region	NA	NA	hsa04115:p53 signaling pathway;hsa04610:Complement and coagulation cascades
CYR61	GO:0010033~response to organic substance;GO:0007155~cell adhesion;GO:0007626~locomotory behavior;GO:0008283~cell proliferation;GO:0001525~angiogenesis;GO:0030198~extracellular matrix organization;GO:0048514~blood vessel morphogenesis;GO:0042330~taxis;GO:0006935~chemotaxis;GO:0001944~vasculature development;GO:0040008~regulation of growth;GO:0001558~regulation of cell growth;GO:0043062~extracellular structure organization;GO:0001568~blood vessel development;GO:0022610~biological adhesion	GO:0005576~extracellular region	GO:0030246~carbohydrate binding;GO:0005539~glycosaminoglycan binding;GO:0008201~heparin binding;GO:0019838~growth factor binding;GO:0030247~polysaccharide binding;GO:0005520~insulin-like growth factor binding;GO:0001871~pattern binding	IPR000867:Insulin-like growth factor-binding protein, IGFBP;IPR017891:Insulin-like growth factor binding protein, N-terminal;IPR000884:Thrombospondin, type 1 repeat	NA
CRISPLD2	GO:0043062~extracellular structure organization;GO:0030198~extracellular matrix organization	GO:0031982~vesicle;GO:0031012~extracellular matrix;GO:0031410~cytoplasmic vesicle;GO:0031988~membrane-bounded vesicle;GO:0005576~extracellular region;GO:0044421~extracellular region part;GO:0016023~cytoplasmic membrane-bounded vesicle	GO:0030246~carbohydrate binding;GO:0005539~glycosaminoglycan binding;GO:0008201~heparin binding;GO:0030247~polysaccharide binding;GO:0001871~pattern binding	NA	NA
DIO2	GO:0009628~response to abiotic stimulus	GO:0005886~plasma membrane	NA	NA	NA
S100A12	GO:0006952~defense response;GO:0009611~response to wounding;GO:0009617~response to bacterium;GO:0006954~inflammatory response	GO:0005886~plasma membrane;GO:0005730~nucleolus	GO:0005509~calcium ion binding	NA	NA
DUSP8	GO:0006469~negative regulation of protein kinase activity;GO:0045859~regulation of protein kinase activity;GO:0051174~regulation of phosphorus metabolic process;GO:0051338~regulation of transferase activity;GO:0051348~negative regulation of transferase activity;GO:0043549~regulation of kinase activity;GO:0042325~regulation of phosphorylation;GO:0019220~regulation of phosphate metabolic process;GO:0033673~negative regulation of kinase activity	NA	NA	NA	hsa04010:MAPK signaling pathway
LYVE1	GO:0007155~cell adhesion;GO:0006928~cell motion;GO:0009611~response to wounding;GO:0022610~biological adhesion	GO:0005886~plasma membrane;GO:0031226~intrinsic to plasma membrane;GO:0005887~integral to plasma membrane;GO:0044459~plasma membrane part	GO:0030246~carbohydrate binding;GO:0005539~glycosaminoglycan binding;GO:0005540~hyaluronic acid binding;GO:0030247~polysaccharide binding;GO:0001871~pattern binding	IPR016186:C-type lectin-like;IPR000538:Link	NA
SYTL4	NA	GO:0005886~plasma membrane;GO:0031982~vesicle;GO:0030141~secretory granule;GO:0031410~cytoplasmic vesicle;GO:0031988~membrane-bounded vesicle;GO:0016023~cytoplasmic membrane-bounded vesicle	NA	NA	NA
PEMT	GO:0007584~response to nutrient;GO:0010033~response to organic substance;GO:0008283~cell proliferation;GO:0033273~response to vitamin;GO:0031667~response to nutrient levels;GO:0042493~response to drug;GO:0008285~negative regulation of cell proliferation;GO:0009719~response to endogenous stimulus;GO:0042127~regulation of cell proliferation;GO:0009991~response to extracellular stimulus	GO:0005886~plasma membrane;GO:0044459~plasma membrane part	NA	NA	NA
ICAM1	GO:0051270~regulation of cell motion;GO:0002263~cell activation during immune response;GO:0050900~leukocyte migration;GO:0002443~leukocyte mediated immunity;GO:0040017~positive regulation of locomotion;GO:0002252~immune effector process;GO:0006955~immune response;GO:0030334~regulation of cell migration;GO:0007157~heterophilic cell adhesion;GO:0051272~positive regulation of cell motion;GO:0051674~localization of cell;GO:0002250~adaptive immune response;GO:0030335~positive regulation of cell migration;GO:0006928~cell motion;GO:0048870~cell motility;GO:0007155~cell adhesion;GO:0002366~leukocyte activation during immune response;GO:0002285~lymphocyte activation during immune response;GO:0040012~regulation of locomotion;GO:0016477~cell migration;GO:0002286~T cell activation during immune response;GO:0044093~positive regulation of molecular function;GO:0002460~adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains;GO:0022610~biological adhesion;GO:0002684~positive regulation of immune system process	GO:0005887~integral to plasma membrane;GO:0005576~extracellular region;GO:0044459~plasma membrane part;GO:0005615~extracellular space;GO:0031226~intrinsic to plasma membrane;GO:0005886~plasma membrane;GO:0044421~extracellular region part;GO:0009986~cell surface	GO:0032403~protein complex binding;GO:0005178~integrin binding	IPR013783:Immunoglobulin-like fold;IPR003599:Immunoglobulin subtype	NA
GADD45B	GO:0045859~regulation of protein kinase activity;GO:0051348~negative regulation of transferase activity;GO:0042325~regulation of phosphorylation;GO:0051347~positive regulation of transferase activity;GO:0006469~negative regulation of protein kinase activity;GO:0051174~regulation of phosphorus metabolic process;GO:0006915~apoptosis;GO:0045860~positive regulation of protein kinase activity;GO:0051338~regulation of transferase activity;GO:0043085~positive regulation of catalytic activity;GO:0033673~negative regulation of kinase activity;GO:0051726~regulation of cell cycle;GO:0012501~programmed cell death;GO:0019220~regulation of phosphate metabolic process;GO:0008219~cell death;GO:0016265~death;GO:0044093~positive regulation of molecular function;GO:0043549~regulation of kinase activity;GO:0033674~positive regulation of kinase activity	NA	NA	NA	hsa04115:p53 signaling pathway;hsa04010:MAPK signaling pathway
METRNL	NA	GO:0005576~extracellular region	NA	NA	NA
GPD1L	NA	NA	GO:0046983~protein dimerization activity;GO:0042803~protein homodimerization activity	NA	NA
CCND1	GO:0051412~response to corticosterone stimulus;GO:0009314~response to radiation;GO:0043627~response to estrogen stimulus;GO:0051347~positive regulation of transferase activity;GO:0051174~regulation of phosphorus metabolic process;GO:0014070~response to organic cyclic substance;GO:0051338~regulation of transferase activity;GO:0008284~positive regulation of cell proliferation;GO:0051726~regulation of cell cycle;GO:0033273~response to vitamin;GO:0031667~response to nutrient levels;GO:0009991~response to extracellular stimulus;GO:0009411~response to UV;GO:0009968~negative regulation of signal transduction;GO:0010033~response to organic substance;GO:0045859~regulation of protein kinase activity;GO:0051329~interphase of mitotic cell cycle;GO:0022403~cell cycle phase;GO:0048545~response to steroid hormone stimulus;GO:0042325~regulation of phosphorylation;GO:0000082~G1/S transition of mitotic cell cycle;GO:0000079~regulation of cyclin-dependent protein kinase activity;GO:0051384~response to glucocorticoid stimulus;GO:0045860~positive regulation of protein kinase activity;GO:0043085~positive regulation of catalytic activity;GO:0051325~interphase;GO:0010212~response to ionizing radiation;GO:0007584~response to nutrient;GO:0009725~response to hormone stimulus;GO:0009628~response to abiotic stimulus;GO:0045596~negative regulation of cell differentiation;GO:0045787~positive regulation of cell cycle;GO:0019220~regulation of phosphate metabolic process;GO:0045737~positive regulation of cyclin-dependent protein kinase activity;GO:0031100~organ regeneration;GO:0031099~regeneration;GO:0031960~response to corticosteroid stimulus;GO:0042493~response to drug;GO:0009719~response to endogenous stimulus;GO:0044093~positive regulation of molecular function;GO:0043549~regulation of kinase activity;GO:0042127~regulation of cell proliferation;GO:0033674~positive regulation of kinase activity;GO:0051385~response to mineralocorticoid stimulus	GO:0000307~cyclin-dependent protein kinase holoenzyme complex	GO:0032403~protein complex binding	NA	hsa05220:Chronic myeloid leukemia;hsa04115:p53 signaling pathway
HID1	GO:0048568~embryonic organ development	NA	GO:0046983~protein dimerization activity;GO:0042803~protein homodimerization activity	NA	NA
AZGP1	GO:0007155~cell adhesion;GO:0008285~negative regulation of cell proliferation;GO:0006955~immune response;GO:0042127~regulation of cell proliferation;GO:0022610~biological adhesion	GO:0005886~plasma membrane;GO:0005576~extracellular region;GO:0044459~plasma membrane part	NA	IPR013783:Immunoglobulin-like fold	NA
CYP26B1	GO:0022403~cell cycle phase;GO:0009968~negative regulation of signal transduction	NA	NA	NA	NA
JUNB	GO:0010033~response to organic substance;GO:0045944~positive regulation of transcription from RNA polymerase II promoter;GO:0051412~response to corticosterone stimulus;GO:0009314~response to radiation;GO:0001890~placenta development;GO:0051591~response to cAMP;GO:0048545~response to steroid hormone stimulus;GO:0051384~response to glucocorticoid stimulus;GO:0001944~vasculature development;GO:0034097~response to cytokine stimulus;GO:0014070~response to organic cyclic substance;GO:0007565~female pregnancy;GO:0045597~positive regulation of cell differentiation;GO:0032570~response to progesterone stimulus;GO:0001568~blood vessel development;GO:0001893~maternal placenta development;GO:0051726~regulation of cell cycle;GO:0009725~response to hormone stimulus;GO:0048568~embryonic organ development;GO:0009628~response to abiotic stimulus;GO:0048514~blood vessel morphogenesis;GO:0045896~regulation of transcription, mitotic;GO:0046697~decidualization;GO:0031960~response to corticosteroid stimulus;GO:0042493~response to drug;GO:0009719~response to endogenous stimulus;GO:0051094~positive regulation of developmental process;GO:0051385~response to mineralocorticoid stimulus	GO:0005730~nucleolus	GO:0046983~protein dimerization activity;GO:0003700~transcription factor activity;GO:0043565~sequence-specific DNA binding	IPR004827:Basic-leucine zipper (bZIP) transcription factor;IPR011616:bZIP transcription factor, bZIP-1	NA
MYBPC1	GO:0007155~cell adhesion;GO:0022610~biological adhesion	GO:0030016~myofibril	NA	IPR008957:Fibronectin, type III-like fold;IPR003961:Fibronectin, type III;IPR013783:Immunoglobulin-like fold;IPR003599:Immunoglobulin subtype	NA
MPP1	NA	GO:0005886~plasma membrane;GO:0031226~intrinsic to plasma membrane;GO:0005887~integral to plasma membrane;GO:0044459~plasma membrane part	NA	NA	NA
KLF4	GO:0007584~response to nutrient;GO:0045944~positive regulation of transcription from RNA polymerase II promoter;GO:0048864~stem cell development;GO:0033189~response to vitamin A;GO:0045596~negative regulation of cell differentiation;GO:0019827~stem cell maintenance;GO:0033273~response to vitamin;GO:0031667~response to nutrient levels;GO:0008285~negative regulation of cell proliferation;GO:0009791~post-embryonic development;GO:0048660~regulation of smooth muscle cell proliferation;GO:0042127~regulation of cell proliferation;GO:0009991~response to extracellular stimulus	GO:0005730~nucleolus	GO:0003700~transcription factor activity;GO:0043565~sequence-specific DNA binding	NA	NA
NOP16	NA	GO:0005730~nucleolus	NA	NA	NA
TNFRSF10D	GO:0012501~programmed cell death;GO:0043066~negative regulation of apoptosis;GO:0042981~regulation of apoptosis;GO:0010941~regulation of cell death;GO:0008219~cell death;GO:0006915~apoptosis;GO:0016265~death;GO:0043067~regulation of programmed cell death;GO:0060548~negative regulation of cell death;GO:0043069~negative regulation of programmed cell death	NA	NA	NA	hsa04060:Cytokine-cytokine receptor interaction
CDKN1B	GO:0051270~regulation of cell motion;GO:0042981~regulation of apoptosis;GO:0006469~negative regulation of protein kinase activity;GO:0051174~regulation of phosphorus metabolic process;GO:0051338~regulation of transferase activity;GO:0008361~regulation of cell size;GO:0043065~positive regulation of apoptosis;GO:0043067~regulation of programmed cell death;GO:0033673~negative regulation of kinase activity;GO:0008284~positive regulation of cell proliferation;GO:0051726~regulation of cell cycle;GO:0012501~programmed cell death;GO:0032535~regulation of cellular component size;GO:0008219~cell death;GO:0008285~negative regulation of cell proliferation;GO:0016265~death;GO:0045859~regulation of protein kinase activity;GO:0051329~interphase of mitotic cell cycle;GO:0051348~negative regulation of transferase activity;GO:0022403~cell cycle phase;GO:0042325~regulation of phosphorylation;GO:0000082~G1/S transition of mitotic cell cycle;GO:0000079~regulation of cyclin-dependent protein kinase activity;GO:0043254~regulation of protein complex assembly;GO:0051325~interphase;GO:0010942~positive regulation of cell death;GO:0051271~negative regulation of cell motion;GO:0019220~regulation of phosphate metabolic process;GO:0043068~positive regulation of programmed cell death;GO:0010941~regulation of cell death;GO:0040008~regulation of growth;GO:0001558~regulation of cell growth;GO:0043549~regulation of kinase activity;GO:0042127~regulation of cell proliferation;GO:0032271~regulation of protein polymerization;GO:0032273~positive regulation of protein polymerization	NA	NA	NA	hsa05220:Chronic myeloid leukemia;hsa04012:ErbB signaling pathway
SLC39A14	GO:0006826~iron ion transport	GO:0005886~plasma membrane	NA	NA	NA
RELB	GO:0002250~adaptive immune response;GO:0002263~cell activation during immune response;GO:0002286~T cell activation during immune response;GO:0002366~leukocyte activation during immune response;GO:0006955~immune response;GO:0002460~adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains;GO:0002285~lymphocyte activation during immune response	NA	GO:0003700~transcription factor activity	IPR000451:NF-kappa-B/Rel/dorsal;IPR011539:Rel homology;IPR013783:Immunoglobulin-like fold	hsa04010:MAPK signaling pathway
S1PR3	GO:0009611~response to wounding;GO:0001817~regulation of cytokine production;GO:0006952~defense response;GO:0006873~cellular ion homeostasis;GO:0055074~calcium ion homeostasis;GO:0006875~cellular metal ion homeostasis;GO:0006954~inflammatory response;GO:0006874~cellular calcium ion homeostasis;GO:0008284~positive regulation of cell proliferation;GO:0030003~cellular cation homeostasis;GO:0050801~ion homeostasis;GO:0055080~cation homeostasis;GO:0019725~cellular homeostasis;GO:0007204~elevation of cytosolic calcium ion concentration;GO:0055082~cellular chemical homeostasis;GO:0055065~metal ion homeostasis;GO:0055066~di-, tri-valent inorganic cation homeostasis;GO:0030005~cellular di-, tri-valent inorganic cation homeostasis;GO:0048878~chemical homeostasis;GO:0042592~homeostatic process;GO:0042127~regulation of cell proliferation	GO:0005886~plasma membrane;GO:0031226~intrinsic to plasma membrane;GO:0005887~integral to plasma membrane;GO:0044459~plasma membrane part	NA	NA	NA
LILRB5	GO:0006952~defense response;GO:0006955~immune response	NA	NA	IPR013783:Immunoglobulin-like fold;IPR003599:Immunoglobulin subtype	NA
PLA2G6	GO:0008219~cell death;GO:0016265~death	NA	NA	NA	hsa04010:MAPK signaling pathway
CITED2	GO:0051270~regulation of cell motion;GO:0045944~positive regulation of transcription from RNA polymerase II promoter;GO:0001890~placenta development;GO:0030334~regulation of cell migration;GO:0042981~regulation of apoptosis;GO:0001944~vasculature development;GO:0001666~response to hypoxia;GO:0007565~female pregnancy;GO:0043067~regulation of programmed cell death;GO:0001568~blood vessel development;GO:0051271~negative regulation of cell motion;GO:0001893~maternal placenta development;GO:0051726~regulation of cell cycle;GO:0048568~embryonic organ development;GO:0045787~positive regulation of cell cycle;GO:0048514~blood vessel morphogenesis;GO:0043066~negative regulation of apoptosis;GO:0045896~regulation of transcription, mitotic;GO:0040013~negative regulation of locomotion;GO:0030336~negative regulation of cell migration;GO:0040012~regulation of locomotion;GO:0046697~decidualization;GO:0010941~regulation of cell death;GO:0060548~negative regulation of cell death;GO:0070482~response to oxygen levels;GO:0043069~negative regulation of programmed cell death	NA	GO:0003700~transcription factor activity	NA	NA
NFATC1	GO:0051329~interphase of mitotic cell cycle;GO:0022403~cell cycle phase;GO:0051325~interphase;GO:0000082~G1/S transition of mitotic cell cycle	NA	GO:0003700~transcription factor activity;GO:0043565~sequence-specific DNA binding	IPR000451:NF-kappa-B/Rel/dorsal;IPR011539:Rel homology;IPR013783:Immunoglobulin-like fold	NA
SBNO2	GO:0002263~cell activation during immune response;GO:0050727~regulation of inflammatory response;GO:0032101~regulation of response to external stimulus;GO:0002366~leukocyte activation during immune response;GO:0006955~immune response	NA	NA	NA	NA
TNFAIP3	GO:0012501~programmed cell death;GO:0043066~negative regulation of apoptosis;GO:0042981~regulation of apoptosis;GO:0010941~regulation of cell death;GO:0008219~cell death;GO:0006915~apoptosis;GO:0016265~death;GO:0043067~regulation of programmed cell death;GO:0060548~negative regulation of cell death;GO:0009968~negative regulation of signal transduction;GO:0043069~negative regulation of programmed cell death	NA	NA	NA	NA
SLC4A1	GO:0050801~ion homeostasis;GO:0019725~cellular homeostasis;GO:0042592~homeostatic process;GO:0055082~cellular chemical homeostasis;GO:0006873~cellular ion homeostasis;GO:0048878~chemical homeostasis	GO:0005886~plasma membrane;GO:0031226~intrinsic to plasma membrane;GO:0005887~integral to plasma membrane;GO:0030016~myofibril;GO:0016323~basolateral plasma membrane;GO:0044459~plasma membrane part	GO:0046983~protein dimerization activity;GO:0042803~protein homodimerization activity	IPR011531:Bicarbonate transporter, C-terminal;IPR003020:Bicarbonate transporter, eukaryotic;IPR013769:Bicarbonate transporter, cytoplasmic	NA
HIST1H1B	GO:0007517~muscle organ development	NA	NA	NA	NA
CD163	GO:0006953~acute-phase response;GO:0006952~defense response;GO:0002526~acute inflammatory response;GO:0009611~response to wounding;GO:0006954~inflammatory response	GO:0005886~plasma membrane;GO:0031226~intrinsic to plasma membrane;GO:0005887~integral to plasma membrane;GO:0005576~extracellular region;GO:0044459~plasma membrane part	GO:0005044~scavenger receptor activity	IPR017448:Speract/scavenger receptor related;IPR001190:Speract/scavenger receptor	NA
USP2	NA	GO:0005886~plasma membrane	NA	NA	NA
HIF3A	GO:0001666~response to hypoxia;GO:0070482~response to oxygen levels	NA	GO:0003700~transcription factor activity	NA	NA
SLC2A1	GO:0009628~response to abiotic stimulus	GO:0031982~vesicle;GO:0031410~cytoplasmic vesicle;GO:0045121~membrane raft;GO:0031988~membrane-bounded vesicle;GO:0016323~basolateral plasma membrane;GO:0044459~plasma membrane part;GO:0005886~plasma membrane;GO:0016023~cytoplasmic membrane-bounded vesicle	NA	NA	NA
COLEC12	GO:0010033~response to organic substance;GO:0006952~defense response;GO:0045087~innate immune response;GO:0006955~immune response	NA	GO:0030246~carbohydrate binding;GO:0005044~scavenger receptor activity;GO:0005509~calcium ion binding	IPR018378:C-type lectin, conserved site;IPR001304:C-type lectin;IPR016186:C-type lectin-like	NA
CD14	GO:0010033~response to organic substance;GO:0012501~programmed cell death;GO:0006955~immune response;GO:0009611~response to wounding;GO:0008219~cell death;GO:0006952~defense response;GO:0051240~positive regulation of multicellular organismal process;GO:0001817~regulation of cytokine production;GO:0006915~apoptosis;GO:0002237~response to molecule of bacterial origin;GO:0016265~death;GO:0009617~response to bacterium;GO:0032496~response to lipopolysaccharide;GO:0001819~positive regulation of cytokine production;GO:0006954~inflammatory response	GO:0005886~plasma membrane;GO:0045121~membrane raft;GO:0005576~extracellular region	GO:0030246~carbohydrate binding;GO:0005539~glycosaminoglycan binding;GO:0030247~polysaccharide binding;GO:0001871~pattern binding	NA	hsa04010:MAPK signaling pathway;hsa04640:Hematopoietic cell lineage
TUBB2A	GO:0022403~cell cycle phase;GO:0051258~protein polymerization	NA	NA	NA	NA
UAP1	GO:0016051~carbohydrate biosynthetic process;GO:0034637~cellular carbohydrate biosynthetic process	GO:0005730~nucleolus	NA	NA	NA
MT1A	NA	NA	GO:0046870~cadmium ion binding	IPR000006:Metallothionein, vertebrate;IPR003019:Metallothionein superfamily, eukaryotic;IPR018064:Metallothionein, vertebrate, metal binding site	NA
RNF125	GO:0006955~immune response	NA	NA	NA	NA
ATF3	GO:0008284~positive regulation of cell proliferation;GO:0016051~carbohydrate biosynthetic process;GO:0042127~regulation of cell proliferation;GO:0034637~cellular carbohydrate biosynthetic process	GO:0005730~nucleolus	GO:0046983~protein dimerization activity;GO:0003700~transcription factor activity;GO:0043565~sequence-specific DNA binding	IPR004827:Basic-leucine zipper (bZIP) transcription factor;IPR000837:Fos transforming protein	NA
SIK1	GO:0051726~regulation of cell cycle	NA	NA	NA	NA
MT1E	NA	NA	GO:0046870~cadmium ion binding	IPR000006:Metallothionein, vertebrate;IPR003019:Metallothionein superfamily, eukaryotic;IPR018064:Metallothionein, vertebrate, metal binding site	NA
HAS2	NA	GO:0005886~plasma membrane;GO:0031226~intrinsic to plasma membrane;GO:0005887~integral to plasma membrane;GO:0044459~plasma membrane part	NA	IPR001173:Glycosyl transferase, family 2	NA
ARL4A	NA	GO:0005730~nucleolus	NA	NA	NA
CDKN1A	GO:0051412~response to corticosterone stimulus;GO:0009314~response to radiation;GO:0042981~regulation of apoptosis;GO:0006469~negative regulation of protein kinase activity;GO:0050865~regulation of cell activation;GO:0051174~regulation of phosphorus metabolic process;GO:0014070~response to organic cyclic substance;GO:0051338~regulation of transferase activity;GO:0008361~regulation of cell size;GO:0043065~positive regulation of apoptosis;GO:0043067~regulation of programmed cell death;GO:0033673~negative regulation of kinase activity;GO:0008284~positive regulation of cell proliferation;GO:0051726~regulation of cell cycle;GO:0008629~induction of apoptosis by intracellular signals;GO:0043066~negative regulation of apoptosis;GO:0031668~cellular response to extracellular stimulus;GO:0032535~regulation of cellular component size;GO:0008285~negative regulation of cell proliferation;GO:0009991~response to extracellular stimulus;GO:0009411~response to UV;GO:0060548~negative regulation of cell death;GO:0070482~response to oxygen levels;GO:0043069~negative regulation of programmed cell death;GO:0010033~response to organic substance;GO:0045859~regulation of protein kinase activity;GO:0051329~interphase of mitotic cell cycle;GO:0051348~negative regulation of transferase activity;GO:0022403~cell cycle phase;GO:0048545~response to steroid hormone stimulus;GO:0042325~regulation of phosphorylation;GO:0000082~G1/S transition of mitotic cell cycle;GO:0000079~regulation of cyclin-dependent protein kinase activity;GO:0051384~response to glucocorticoid stimulus;GO:0050867~positive regulation of cell activation;GO:0051325~interphase;GO:0010942~positive regulation of cell death;GO:0009725~response to hormone stimulus;GO:0048146~positive regulation of fibroblast proliferation;GO:0009628~response to abiotic stimulus;GO:0019220~regulation of phosphate metabolic process;GO:0043068~positive regulation of programmed cell death;GO:0031100~organ regeneration;GO:0031099~regeneration;GO:0010941~regulation of cell death;GO:0031960~response to corticosteroid stimulus;GO:0042493~response to drug;GO:0040008~regulation of growth;GO:0001558~regulation of cell growth;GO:0009719~response to endogenous stimulus;GO:0043549~regulation of kinase activity;GO:0042127~regulation of cell proliferation;GO:0051385~response to mineralocorticoid stimulus;GO:0002684~positive regulation of immune system process	GO:0000307~cyclin-dependent protein kinase holoenzyme complex	GO:0032403~protein complex binding	NA	hsa05220:Chronic myeloid leukemia;hsa04115:p53 signaling pathway;hsa04012:ErbB signaling pathway
GPC1	NA	GO:0005887~integral to plasma membrane;GO:0031012~extracellular matrix;GO:0005578~proteinaceous extracellular matrix;GO:0005576~extracellular region;GO:0044459~plasma membrane part;GO:0005615~extracellular space;GO:0031226~intrinsic to plasma membrane;GO:0005886~plasma membrane;GO:0009986~cell surface;GO:0044421~extracellular region part	NA	NA	NA
MEOX2	GO:0008015~blood circulation;GO:0001944~vasculature development;GO:0003013~circulatory system process;GO:0001525~angiogenesis;GO:0048514~blood vessel morphogenesis;GO:0007517~muscle organ development;GO:0001568~blood vessel development	NA	GO:0003700~transcription factor activity;GO:0043565~sequence-specific DNA binding	NA	NA
TFRC	GO:0010033~response to organic substance;GO:0033189~response to vitamin A;GO:0009611~response to wounding;GO:0006953~acute-phase response;GO:0001666~response to hypoxia;GO:0006952~defense response;GO:0006873~cellular ion homeostasis;GO:0002526~acute inflammatory response;GO:0055072~iron ion homeostasis;GO:0006954~inflammatory response;GO:0050801~ion homeostasis;GO:0007584~response to nutrient;GO:0030003~cellular cation homeostasis;GO:0019725~cellular homeostasis;GO:0055080~cation homeostasis;GO:0055082~cellular chemical homeostasis;GO:0055066~di-, tri-valent inorganic cation homeostasis;GO:0030005~cellular di-, tri-valent inorganic cation homeostasis;GO:0048878~chemical homeostasis;GO:0006879~cellular iron ion homeostasis;GO:0033273~response to vitamin;GO:0031667~response to nutrient levels;GO:0042592~homeostatic process;GO:0009991~response to extracellular stimulus;GO:0070482~response to oxygen levels	GO:0031982~vesicle;GO:0005887~integral to plasma membrane;GO:0031410~cytoplasmic vesicle;GO:0031988~membrane-bounded vesicle;GO:0005576~extracellular region;GO:0044459~plasma membrane part;GO:0031226~intrinsic to plasma membrane;GO:0005886~plasma membrane;GO:0016023~cytoplasmic membrane-bounded vesicle	NA	NA	hsa04640:Hematopoietic cell lineage
LRG1	NA	GO:0005576~extracellular region	NA	NA	NA
PLAUR	GO:0007599~hemostasis;GO:0007626~locomotory behavior;GO:0009611~response to wounding;GO:0042330~taxis;GO:0006935~chemotaxis;GO:0050878~regulation of body fluid levels;GO:0031099~regeneration;GO:0042060~wound healing;GO:0006928~cell motion;GO:0050817~coagulation;GO:0007596~blood coagulation	GO:0005886~plasma membrane;GO:0009986~cell surface;GO:0005576~extracellular region	NA	NA	hsa04610:Complement and coagulation cascades
NNMT	NA	NA	NA	NA	hsa00760:Nicotinate and nicotinamide metabolism
DLL4	GO:0008015~blood circulation;GO:0051271~negative regulation of cell motion;GO:0051270~regulation of cell motion;GO:0001525~angiogenesis;GO:0048514~blood vessel morphogenesis;GO:0030334~regulation of cell migration;GO:0040013~negative regulation of locomotion;GO:0030336~negative regulation of cell migration;GO:0040012~regulation of locomotion;GO:0001944~vasculature development;GO:0003013~circulatory system process;GO:0001568~blood vessel development	NA	GO:0005509~calcium ion binding	IPR013032:EGF-like region, conserved site;IPR006210:EGF-like;IPR006209:EGF;IPR001881:EGF-like calcium-binding;IPR000742:EGF-like, type 3	NA
FNDC4	NA	NA	NA	IPR008957:Fibronectin, type III-like fold;IPR003961:Fibronectin, type III	NA
NR4A2	GO:0010033~response to organic substance;GO:0045944~positive regulation of transcription from RNA polymerase II promoter;GO:0007626~locomotory behavior;GO:0042981~regulation of apoptosis;GO:0051674~localization of cell;GO:0001666~response to hypoxia;GO:0006928~cell motion;GO:0009791~post-embryonic development;GO:0043085~positive regulation of catalytic activity;GO:0043067~regulation of programmed cell death;GO:0048870~cell motility;GO:0043066~negative regulation of apoptosis;GO:0031668~cellular response to extracellular stimulus;GO:0016477~cell migration;GO:0010941~regulation of cell death;GO:0044093~positive regulation of molecular function;GO:0009719~response to endogenous stimulus;GO:0016265~death;GO:0009991~response to extracellular stimulus;GO:0070482~response to oxygen levels;GO:0060548~negative regulation of cell death;GO:0043069~negative regulation of programmed cell death	NA	GO:0046983~protein dimerization activity;GO:0003700~transcription factor activity;GO:0043565~sequence-specific DNA binding	IPR003070:Orphan nuclear receptor	NA
NCR3LG1	NA	NA	NA	IPR013783:Immunoglobulin-like fold;IPR003599:Immunoglobulin subtype	NA
CBLB	GO:0050865~regulation of cell activation;GO:0008285~negative regulation of cell proliferation;GO:0006955~immune response;GO:0042127~regulation of cell proliferation;GO:0009968~negative regulation of signal transduction;GO:0002684~positive regulation of immune system process	NA	GO:0005509~calcium ion binding	NA	hsa05220:Chronic myeloid leukemia;hsa04012:ErbB signaling pathway
WNT9A	GO:0001501~skeletal system development;GO:0048568~embryonic organ development;GO:0045597~positive regulation of cell differentiation;GO:0051094~positive regulation of developmental process;GO:0048705~skeletal system morphogenesis	GO:0031012~extracellular matrix;GO:0005578~proteinaceous extracellular matrix;GO:0005576~extracellular region;GO:0044421~extracellular region part	NA	NA	NA
OR51E1	NA	GO:0005886~plasma membrane	NA	NA	NA
NKX3-1	GO:0008285~negative regulation of cell proliferation;GO:0042127~regulation of cell proliferation	NA	GO:0003700~transcription factor activity;GO:0043565~sequence-specific DNA binding	NA	NA
CABP1	NA	GO:0005886~plasma membrane;GO:0044459~plasma membrane part	GO:0005509~calcium ion binding	NA	NA
SEMA3C	GO:0016477~cell migration;GO:0001944~vasculature development;GO:0042493~response to drug;GO:0006928~cell motion;GO:0009791~post-embryonic development;GO:0006955~immune response;GO:0048514~blood vessel morphogenesis;GO:0048870~cell motility;GO:0051674~localization of cell;GO:0001568~blood vessel development	GO:0005615~extracellular space;GO:0005576~extracellular region;GO:0044421~extracellular region part	NA	IPR013783:Immunoglobulin-like fold;IPR003599:Immunoglobulin subtype	NA
NTN1	GO:0051270~regulation of cell motion;GO:0031344~regulation of cell projection organization;GO:0022604~regulation of cell morphogenesis;GO:0030334~regulation of cell migration;GO:0051674~localization of cell;GO:0045793~positive regulation of cell size;GO:0006928~cell motion;GO:0006915~apoptosis;GO:0031346~positive regulation of cell projection organization;GO:0008361~regulation of cell size;GO:0045597~positive regulation of cell differentiation;GO:0048870~cell motility;GO:0008284~positive regulation of cell proliferation;GO:0045773~positive regulation of axon extension;GO:0012501~programmed cell death;GO:0030307~positive regulation of cell growth;GO:0045596~negative regulation of cell differentiation;GO:0040012~regulation of locomotion;GO:0016477~cell migration;GO:0032535~regulation of cellular component size;GO:0040008~regulation of growth;GO:0008219~cell death;GO:0001558~regulation of cell growth;GO:0016265~death;GO:0042127~regulation of cell proliferation;GO:0051094~positive regulation of developmental process	GO:0031012~extracellular matrix;GO:0005578~proteinaceous extracellular matrix;GO:0005576~extracellular region;GO:0044421~extracellular region part	NA	IPR013032:EGF-like region, conserved site	NA
PTPRD	NA	GO:0005886~plasma membrane;GO:0031226~intrinsic to plasma membrane;GO:0005887~integral to plasma membrane;GO:0044459~plasma membrane part	NA	IPR008957:Fibronectin, type III-like fold;IPR003961:Fibronectin, type III;IPR013783:Immunoglobulin-like fold	NA
PERP	GO:0012501~programmed cell death;GO:0007155~cell adhesion;GO:0042981~regulation of apoptosis;GO:0043068~positive regulation of programmed cell death;GO:0010941~regulation of cell death;GO:0008219~cell death;GO:0006915~apoptosis;GO:0016265~death;GO:0043067~regulation of programmed cell death;GO:0043065~positive regulation of apoptosis;GO:0010942~positive regulation of cell death;GO:0022610~biological adhesion	GO:0005886~plasma membrane;GO:0031226~intrinsic to plasma membrane;GO:0005887~integral to plasma membrane;GO:0044459~plasma membrane part	NA	NA	hsa04115:p53 signaling pathway
PRRX2	GO:0001501~skeletal system development;GO:0008284~positive regulation of cell proliferation;GO:0001944~vasculature development;GO:0048568~embryonic organ development;GO:0042127~regulation of cell proliferation;GO:0048514~blood vessel morphogenesis;GO:0048705~skeletal system morphogenesis;GO:0001568~blood vessel development	NA	GO:0003700~transcription factor activity;GO:0043565~sequence-specific DNA binding	NA	NA
ALDH1A3	GO:0010941~regulation of cell death;GO:0042493~response to drug;GO:0048568~embryonic organ development;GO:0043065~positive regulation of apoptosis;GO:0043067~regulation of programmed cell death;GO:0010942~positive regulation of cell death;GO:0042981~regulation of apoptosis;GO:0043068~positive regulation of programmed cell death	NA	GO:0046983~protein dimerization activity;GO:0042803~protein homodimerization activity	NA	NA
SLC25A25	NA	NA	GO:0005509~calcium ion binding	NA	NA
NR4A3	GO:0031099~regeneration;GO:0010033~response to organic substance;GO:0009725~response to hormone stimulus;GO:0045944~positive regulation of transcription from RNA polymerase II promoter;GO:0048568~embryonic organ development;GO:0009719~response to endogenous stimulus;GO:0031100~organ regeneration	NA	GO:0003700~transcription factor activity;GO:0043565~sequence-specific DNA binding	IPR003070:Orphan nuclear receptor	NA
PPARGC1B	GO:0051384~response to glucocorticoid stimulus;GO:0010033~response to organic substance;GO:0031960~response to corticosteroid stimulus;GO:0009725~response to hormone stimulus;GO:0045944~positive regulation of transcription from RNA polymerase II promoter;GO:0051591~response to cAMP;GO:0009719~response to endogenous stimulus;GO:0048545~response to steroid hormone stimulus	NA	NA	NA	NA
SHB	GO:0012501~programmed cell death;GO:0008283~cell proliferation;GO:0001525~angiogenesis;GO:0048514~blood vessel morphogenesis;GO:0001944~vasculature development;GO:0008219~cell death;GO:0006915~apoptosis;GO:0016265~death;GO:0001568~blood vessel development	GO:0005886~plasma membrane;GO:0044459~plasma membrane part	NA	NA	NA
PECR	GO:0010941~regulation of cell death;GO:0046394~carboxylic acid biosynthetic process;GO:0043067~regulation of programmed cell death;GO:0016053~organic acid biosynthetic process;GO:0042981~regulation of apoptosis	NA	NA	NA	NA
ABL2	GO:0051353~positive regulation of oxidoreductase activity;GO:0030036~actin cytoskeleton organization;GO:0030029~actin filament-based process;GO:0007010~cytoskeleton organization;GO:0007155~cell adhesion;GO:0043085~positive regulation of catalytic activity;GO:0044093~positive regulation of molecular function;GO:0007015~actin filament organization;GO:0022610~biological adhesion	NA	NA	NA	hsa04012:ErbB signaling pathway
SLC4A4	NA	GO:0005886~plasma membrane;GO:0031226~intrinsic to plasma membrane;GO:0005887~integral to plasma membrane;GO:0044459~plasma membrane part	NA	IPR011531:Bicarbonate transporter, C-terminal;IPR003020:Bicarbonate transporter, eukaryotic;IPR013769:Bicarbonate transporter, cytoplasmic	NA
MARCO	NA	GO:0005886~plasma membrane;GO:0031226~intrinsic to plasma membrane;GO:0005887~integral to plasma membrane;GO:0044459~plasma membrane part	GO:0005044~scavenger receptor activity	IPR017448:Speract/scavenger receptor related;IPR001190:Speract/scavenger receptor	NA
ENOX1	GO:0048511~rhythmic process	GO:0005886~plasma membrane;GO:0005615~extracellular space;GO:0005576~extracellular region;GO:0044421~extracellular region part	NA	NA	NA
PROK1	GO:0045859~regulation of protein kinase activity;GO:0042325~regulation of phosphorylation;GO:0051347~positive regulation of transferase activity;GO:0045765~regulation of angiogenesis;GO:0001944~vasculature development;GO:0051174~regulation of phosphorus metabolic process;GO:0045860~positive regulation of protein kinase activity;GO:0051338~regulation of transferase activity;GO:0043085~positive regulation of catalytic activity;GO:0001568~blood vessel development;GO:0008284~positive regulation of cell proliferation;GO:0001525~angiogenesis;GO:0048514~blood vessel morphogenesis;GO:0019220~regulation of phosphate metabolic process;GO:0044093~positive regulation of molecular function;GO:0042127~regulation of cell proliferation;GO:0043549~regulation of kinase activity;GO:0033674~positive regulation of kinase activity	GO:0005576~extracellular region	GO:0008083~growth factor activity	NA	NA
FSTL3	GO:0009968~negative regulation of signal transduction	GO:0031982~vesicle;GO:0030141~secretory granule;GO:0031410~cytoplasmic vesicle;GO:0031988~membrane-bounded vesicle;GO:0005576~extracellular region;GO:0005615~extracellular space;GO:0044421~extracellular region part;GO:0016023~cytoplasmic membrane-bounded vesicle	GO:0032403~protein complex binding	NA	NA
PTPRQ	GO:0048568~embryonic organ development	NA	NA	IPR008957:Fibronectin, type III-like fold;IPR003961:Fibronectin, type III	NA
URB2	NA	GO:0005730~nucleolus	NA	NA	NA
ADGRG3	NA	GO:0005886~plasma membrane	NA	NA	NA
AEN	GO:0010212~response to ionizing radiation;GO:0012501~programmed cell death;GO:0009314~response to radiation;GO:0009628~response to abiotic stimulus;GO:0008629~induction of apoptosis by intracellular signals;GO:0042981~regulation of apoptosis;GO:0008630~DNA damage response, signal transduction resulting in induction of apoptosis;GO:0043068~positive regulation of programmed cell death;GO:0010941~regulation of cell death;GO:0008219~cell death;GO:0006915~apoptosis;GO:0016265~death;GO:0043067~regulation of programmed cell death;GO:0043065~positive regulation of apoptosis;GO:0010942~positive regulation of cell death	GO:0005730~nucleolus	NA	NA	NA
ENTPD3	NA	GO:0005886~plasma membrane	GO:0005509~calcium ion binding	NA	NA
SCN4B	NA	GO:0005886~plasma membrane;GO:0031226~intrinsic to plasma membrane;GO:0005887~integral to plasma membrane;GO:0044459~plasma membrane part	NA	IPR013783:Immunoglobulin-like fold;IPR003599:Immunoglobulin subtype	NA
DPP4	GO:0001666~response to hypoxia;GO:0070482~response to oxygen levels	GO:0005886~plasma membrane;GO:0009986~cell surface;GO:0005625~soluble fraction;GO:0005576~extracellular region;GO:0044459~plasma membrane part	GO:0005518~collagen binding;GO:0046983~protein dimerization activity;GO:0042803~protein homodimerization activity;GO:0042277~peptide binding	NA	NA
EGR3	GO:0048511~rhythmic process;GO:0007517~muscle organ development	NA	GO:0003700~transcription factor activity	NA	NA
MKI67	GO:0008283~cell proliferation;GO:0022403~cell cycle phase	GO:0005730~nucleolus	NA	NA	NA
NOLC1	GO:0022403~cell cycle phase	GO:0005730~nucleolus	NA	NA	NA
EMILIN2	GO:0007155~cell adhesion;GO:0022610~biological adhesion	GO:0031012~extracellular matrix;GO:0005578~proteinaceous extracellular matrix;GO:0005576~extracellular region;GO:0044421~extracellular region part	NA	NA	NA
SAA1	GO:0050727~regulation of inflammatory response;GO:0048246~macrophage chemotaxis;GO:0007626~locomotory behavior;GO:0009611~response to wounding;GO:0060326~cell chemotaxis;GO:0006953~acute-phase response;GO:0030595~leukocyte chemotaxis;GO:0001817~regulation of cytokine production;GO:0006873~cellular ion homeostasis;GO:0006874~cellular calcium ion homeostasis;GO:0050801~ion homeostasis;GO:0030003~cellular cation homeostasis;GO:0019725~cellular homeostasis;GO:0055080~cation homeostasis;GO:0055065~metal ion homeostasis;GO:0055066~di-, tri-valent inorganic cation homeostasis;GO:0030005~cellular di-, tri-valent inorganic cation homeostasis;GO:0050878~regulation of body fluid levels;GO:0051240~positive regulation of multicellular organismal process;GO:0042592~homeostatic process;GO:0001819~positive regulation of cytokine production;GO:0050900~leukocyte migration;GO:0042330~taxis;GO:0051674~localization of cell;GO:0006935~chemotaxis;GO:0006928~cell motion;GO:0006952~defense response;GO:0002526~acute inflammatory response;GO:0050817~coagulation;GO:0055074~calcium ion homeostasis;GO:0048870~cell motility;GO:0006954~inflammatory response;GO:0006875~cellular metal ion homeostasis;GO:0007599~hemostasis;GO:0007204~elevation of cytosolic calcium ion concentration;GO:0055082~cellular chemical homeostasis;GO:0048878~chemical homeostasis;GO:0016477~cell migration;GO:0042060~wound healing;GO:0032101~regulation of response to external stimulus;GO:0007596~blood coagulation	GO:0034358~plasma lipoprotein particle;GO:0005615~extracellular space;GO:0005576~extracellular region;GO:0044421~extracellular region part;GO:0032994~protein-lipid complex	NA	NA	NA
PAMR1	NA	GO:0005576~extracellular region	NA	IPR000436:Sushi/SCR/CCP;IPR013032:EGF-like region, conserved site;IPR006210:EGF-like;IPR006209:EGF;IPR016060:Complement control module;IPR000742:EGF-like, type 3	NA
EPB41L3	GO:0030036~actin cytoskeleton organization;GO:0030029~actin filament-based process;GO:0007010~cytoskeleton organization	GO:0005886~plasma membrane;GO:0044459~plasma membrane part	NA	NA	NA
KIAA0226L	GO:0051174~regulation of phosphorus metabolic process;GO:0019220~regulation of phosphate metabolic process	NA	NA	NA	NA
EGFLAM	GO:0043062~extracellular structure organization;GO:0030198~extracellular matrix organization	GO:0005886~plasma membrane;GO:0031012~extracellular matrix;GO:0005578~proteinaceous extracellular matrix;GO:0005576~extracellular region;GO:0044421~extracellular region part;GO:0044459~plasma membrane part	GO:0030246~carbohydrate binding;GO:0005539~glycosaminoglycan binding;GO:0030247~polysaccharide binding;GO:0001871~pattern binding	IPR013032:EGF-like region, conserved site;IPR006210:EGF-like;IPR006209:EGF;IPR008957:Fibronectin, type III-like fold;IPR003961:Fibronectin, type III;IPR000742:EGF-like, type 3	NA
RND3	GO:0030036~actin cytoskeleton organization;GO:0030029~actin filament-based process;GO:0007010~cytoskeleton organization;GO:0007155~cell adhesion;GO:0022610~biological adhesion	NA	NA	NA	NA
DDX21	NA	GO:0005730~nucleolus	NA	NA	NA
CD300E	GO:0006955~immune response	GO:0005886~plasma membrane	NA	IPR013783:Immunoglobulin-like fold;IPR003599:Immunoglobulin subtype	NA
HCAR2	GO:0012501~programmed cell death;GO:0042981~regulation of apoptosis;GO:0043068~positive regulation of programmed cell death;GO:0010941~regulation of cell death;GO:0008219~cell death;GO:0006915~apoptosis;GO:0042592~homeostatic process;GO:0016265~death;GO:0043067~regulation of programmed cell death;GO:0043065~positive regulation of apoptosis;GO:0010942~positive regulation of cell death	GO:0005886~plasma membrane;GO:0031226~intrinsic to plasma membrane;GO:0005887~integral to plasma membrane;GO:0044459~plasma membrane part	NA	NA	NA
F2RL3	GO:0050878~regulation of body fluid levels;GO:0007599~hemostasis;GO:0042060~wound healing;GO:0050817~coagulation;GO:0044093~positive regulation of molecular function;GO:0043085~positive regulation of catalytic activity;GO:0009611~response to wounding;GO:0007596~blood coagulation	GO:0005886~plasma membrane;GO:0031226~intrinsic to plasma membrane;GO:0005887~integral to plasma membrane;GO:0005576~extracellular region;GO:0044459~plasma membrane part	GO:0008528~peptide receptor activity, G-protein coupled;GO:0042277~peptide binding;GO:0001653~peptide receptor activity	NA	NA
FLNC	NA	GO:0005886~plasma membrane;GO:0030016~myofibril	NA	IPR013783:Immunoglobulin-like fold	hsa04010:MAPK signaling pathway
SFRP4	GO:0007565~female pregnancy	GO:0005615~extracellular space;GO:0005576~extracellular region;GO:0044421~extracellular region part	NA	NA	NA
EMP1	GO:0032535~regulation of cellular component size;GO:0008283~cell proliferation;GO:0008361~regulation of cell size	GO:0005886~plasma membrane	NA	NA	NA
RASD1	NA	GO:0005886~plasma membrane;GO:0005625~soluble fraction;GO:0044459~plasma membrane part	NA	NA	NA
PTGIS	GO:0046394~carboxylic acid biosynthetic process;GO:0016053~organic acid biosynthetic process;GO:0042981~regulation of apoptosis;GO:0043068~positive regulation of programmed cell death;GO:0010941~regulation of cell death;GO:0006690~icosanoid metabolic process;GO:0043067~regulation of programmed cell death;GO:0043065~positive regulation of apoptosis;GO:0010942~positive regulation of cell death	NA	NA	NA	NA
PKD1L2	NA	NA	GO:0030246~carbohydrate binding;GO:0005509~calcium ion binding	IPR018378:C-type lectin, conserved site;IPR001304:C-type lectin	NA
FOSL1	GO:0045944~positive regulation of transcription from RNA polymerase II promoter;GO:0051412~response to corticosterone stimulus;GO:0007626~locomotory behavior;GO:0051591~response to cAMP;GO:0042981~regulation of apoptosis;GO:0034097~response to cytokine stimulus;GO:0014070~response to organic cyclic substance;GO:0043065~positive regulation of apoptosis;GO:0043067~regulation of programmed cell death;GO:0008284~positive regulation of cell proliferation;GO:0051726~regulation of cell cycle;GO:0031668~cellular response to extracellular stimulus;GO:0008285~negative regulation of cell proliferation;GO:0009991~response to extracellular stimulus;GO:0010033~response to organic substance;GO:0048545~response to steroid hormone stimulus;GO:0042330~taxis;GO:0006935~chemotaxis;GO:0051384~response to glucocorticoid stimulus;GO:0006952~defense response;GO:0007565~female pregnancy;GO:0010942~positive regulation of cell death;GO:0032570~response to progesterone stimulus;GO:0009725~response to hormone stimulus;GO:0009628~response to abiotic stimulus;GO:0045787~positive regulation of cell cycle;GO:0045896~regulation of transcription, mitotic;GO:0043068~positive regulation of programmed cell death;GO:0010941~regulation of cell death;GO:0042493~response to drug;GO:0031960~response to corticosteroid stimulus;GO:0009719~response to endogenous stimulus;GO:0042127~regulation of cell proliferation;GO:0051385~response to mineralocorticoid stimulus	NA	GO:0046983~protein dimerization activity;GO:0003700~transcription factor activity;GO:0043565~sequence-specific DNA binding	IPR004827:Basic-leucine zipper (bZIP) transcription factor;IPR011616:bZIP transcription factor, bZIP-1;IPR000837:Fos transforming protein	NA
TNFAIP6	GO:0007155~cell adhesion;GO:0006952~defense response;GO:0009611~response to wounding;GO:0022610~biological adhesion;GO:0006954~inflammatory response	NA	GO:0030246~carbohydrate binding;GO:0005539~glycosaminoglycan binding;GO:0005540~hyaluronic acid binding;GO:0030247~polysaccharide binding;GO:0001871~pattern binding	IPR000538:Link	NA
KRT8	GO:0007010~cytoskeleton organization;GO:0012501~programmed cell death;GO:0008219~cell death;GO:0006915~apoptosis;GO:0016265~death	GO:0005886~plasma membrane;GO:0030016~myofibril	NA	NA	NA
DDX3Y	NA	GO:0005886~plasma membrane	NA	NA	NA
LRRN4CL	NA	NA	NA	IPR008957:Fibronectin, type III-like fold;IPR003961:Fibronectin, type III	NA
CTHRC1	GO:0016477~cell migration;GO:0006928~cell motion;GO:0048870~cell motility;GO:0051674~localization of cell	GO:0031012~extracellular matrix;GO:0005578~proteinaceous extracellular matrix;GO:0005576~extracellular region;GO:0044421~extracellular region part	NA	NA	NA
APOLD1	GO:0001666~response to hypoxia;GO:0001944~vasculature development;GO:0001525~angiogenesis;GO:0048514~blood vessel morphogenesis;GO:0070482~response to oxygen levels;GO:0001568~blood vessel development	GO:0005886~plasma membrane;GO:0005576~extracellular region	NA	NA	NA
HLA-DRB5	GO:0006955~immune response	GO:0005886~plasma membrane;GO:0044459~plasma membrane part	NA	IPR013783:Immunoglobulin-like fold	hsa04640:Hematopoietic cell lineage
IL18RAP	GO:0006952~defense response;GO:0045087~innate immune response;GO:0006955~immune response;GO:0009611~response to wounding;GO:0006954~inflammatory response	NA	NA	IPR004075:Interleukin-1 receptor, type I/Toll precursor;IPR015621:Interleukin-1 receptor;IPR013783:Immunoglobulin-like fold;IPR003599:Immunoglobulin subtype	hsa04060:Cytokine-cytokine receptor interaction
HMOX1	GO:0051270~regulation of cell motion;GO:0043627~response to estrogen stimulus;GO:0009611~response to wounding;GO:0030334~regulation of cell migration;GO:0042981~regulation of apoptosis;GO:0008630~DNA damage response, signal transduction resulting in induction of apoptosis;GO:0001666~response to hypoxia;GO:0001944~vasculature development;GO:0050865~regulation of cell activation;GO:0001817~regulation of cytokine production;GO:0014070~response to organic cyclic substance;GO:0002246~healing during inflammatory response;GO:0043065~positive regulation of apoptosis;GO:0043067~regulation of programmed cell death;GO:0001568~blood vessel development;GO:0050801~ion homeostasis;GO:0055080~cation homeostasis;GO:0008629~induction of apoptosis by intracellular signals;GO:0008283~cell proliferation;GO:0001525~angiogenesis;GO:0055066~di-, tri-valent inorganic cation homeostasis;GO:0043066~negative regulation of apoptosis;GO:0048514~blood vessel morphogenesis;GO:0031668~cellular response to extracellular stimulus;GO:0040013~negative regulation of locomotion;GO:0030336~negative regulation of cell migration;GO:0031667~response to nutrient levels;GO:0003013~circulatory system process;GO:0008219~cell death;GO:0051240~positive regulation of multicellular organismal process;GO:0042592~homeostatic process;GO:0008285~negative regulation of cell proliferation;GO:0016265~death;GO:0009991~response to extracellular stimulus;GO:0060548~negative regulation of cell death;GO:0070482~response to oxygen levels;GO:0043069~negative regulation of programmed cell death;GO:0010033~response to organic substance;GO:0048545~response to steroid hormone stimulus;GO:0045765~regulation of angiogenesis;GO:0034381~lipoprotein particle clearance;GO:0006952~defense response;GO:0055072~iron ion homeostasis;GO:0010942~positive regulation of cell death;GO:0006954~inflammatory response;GO:0008015~blood circulation;GO:0051271~negative regulation of cell motion;GO:0007584~response to nutrient;GO:0009725~response to hormone stimulus;GO:0048878~chemical homeostasis;GO:0043068~positive regulation of programmed cell death;GO:0040012~regulation of locomotion;GO:0010941~regulation of cell death;GO:0042060~wound healing;GO:0034383~low-density lipoprotein particle clearance;GO:0009719~response to endogenous stimulus;GO:0042127~regulation of cell proliferation	GO:0005886~plasma membrane;GO:0005615~extracellular space;GO:0005730~nucleolus;GO:0045121~membrane raft;GO:0005576~extracellular region;GO:0044421~extracellular region part;GO:0044459~plasma membrane part	NA	NA	NA
PHGDH	GO:0046394~carboxylic acid biosynthetic process;GO:0016053~organic acid biosynthetic process	NA	NA	NA	NA
SPX	NA	GO:0031982~vesicle;GO:0030141~secretory granule;GO:0031410~cytoplasmic vesicle;GO:0005730~nucleolus;GO:0031988~membrane-bounded vesicle;GO:0005576~extracellular region;GO:0016023~cytoplasmic membrane-bounded vesicle	NA	NA	NA
CH25H	GO:0046394~carboxylic acid biosynthetic process;GO:0016053~organic acid biosynthetic process	NA	NA	NA	NA
BMP3	GO:0001501~skeletal system development;GO:0045944~positive regulation of transcription from RNA polymerase II promoter	GO:0005615~extracellular space;GO:0031982~vesicle;GO:0031988~membrane-bounded vesicle;GO:0005576~extracellular region;GO:0044421~extracellular region part	GO:0008083~growth factor activity	NA	NA
RUNX1	GO:0045765~regulation of angiogenesis;GO:0045944~positive regulation of transcription from RNA polymerase II promoter;GO:0045596~negative regulation of cell differentiation;GO:0045597~positive regulation of cell differentiation;GO:0045766~positive regulation of angiogenesis;GO:0051094~positive regulation of developmental process	NA	GO:0046983~protein dimerization activity;GO:0003700~transcription factor activity;GO:0042803~protein homodimerization activity;GO:0005509~calcium ion binding	NA	hsa05220:Chronic myeloid leukemia
GPR132	GO:0051329~interphase of mitotic cell cycle;GO:0022403~cell cycle phase;GO:0051325~interphase;GO:0000082~G1/S transition of mitotic cell cycle	GO:0005886~plasma membrane	NA	NA	NA
FGF18	GO:0008284~positive regulation of cell proliferation;GO:0001525~angiogenesis;GO:0048514~blood vessel morphogenesis;GO:0048705~skeletal system morphogenesis;GO:0001944~vasculature development;GO:0001501~skeletal system development;GO:0042127~regulation of cell proliferation;GO:0001568~blood vessel development	GO:0005615~extracellular space;GO:0005730~nucleolus;GO:0005576~extracellular region;GO:0044421~extracellular region part	GO:0008083~growth factor activity	NA	hsa04010:MAPK signaling pathway
PLAU	GO:0007626~locomotory behavior;GO:0009611~response to wounding;GO:0042330~taxis;GO:0006935~chemotaxis;GO:0051674~localization of cell;GO:0001666~response to hypoxia;GO:0001944~vasculature development;GO:0006928~cell motion;GO:0050817~coagulation;GO:0007565~female pregnancy;GO:0048870~cell motility;GO:0001568~blood vessel development;GO:0007599~hemostasis;GO:0001525~angiogenesis;GO:0048514~blood vessel morphogenesis;GO:0050878~regulation of body fluid levels;GO:0016477~cell migration;GO:0031099~regeneration;GO:0042060~wound healing;GO:0032101~regulation of response to external stimulus;GO:0042127~regulation of cell proliferation;GO:0070482~response to oxygen levels;GO:0007596~blood coagulation	GO:0005886~plasma membrane;GO:0005576~extracellular region	NA	IPR013032:EGF-like region, conserved site;IPR006210:EGF-like;IPR000742:EGF-like, type 3	hsa04610:Complement and coagulation cascades
VCAN	GO:0007155~cell adhesion;GO:0009611~response to wounding;GO:0051674~localization of cell;GO:0016477~cell migration;GO:0031099~regeneration;GO:0006928~cell motion;GO:0048870~cell motility;GO:0022610~biological adhesion	GO:0031012~extracellular matrix;GO:0005578~proteinaceous extracellular matrix;GO:0005576~extracellular region;GO:0044421~extracellular region part	GO:0030246~carbohydrate binding;GO:0005539~glycosaminoglycan binding;GO:0005540~hyaluronic acid binding;GO:0030247~polysaccharide binding;GO:0001871~pattern binding;GO:0005509~calcium ion binding	IPR000436:Sushi/SCR/CCP;IPR018378:C-type lectin, conserved site;IPR006210:EGF-like;IPR016186:C-type lectin-like;IPR001881:EGF-like calcium-binding;IPR003599:Immunoglobulin subtype;IPR000742:EGF-like, type 3;IPR018097:EGF-like calcium-binding, conserved site;IPR013032:EGF-like region, conserved site;IPR006209:EGF;IPR001304:C-type lectin;IPR016060:Complement control module;IPR000538:Link;IPR013783:Immunoglobulin-like fold	NA
ADAMTS15	NA	GO:0031012~extracellular matrix;GO:0005578~proteinaceous extracellular matrix;GO:0005576~extracellular region;GO:0044421~extracellular region part	NA	IPR010294:ADAM-TS Spacer 1;IPR006025:Peptidase M, neutral zinc metallopeptidases, zinc-binding site;IPR013273:Peptidase M12B, ADAM-TS;IPR001818:Peptidase M10A and M12B, matrixin and adamalysin;IPR000884:Thrombospondin, type 1 repeat	NA
MMP9	GO:0051270~regulation of cell motion;GO:0044236~multicellular organismal metabolic process;GO:0040017~positive regulation of locomotion;GO:0030334~regulation of cell migration;GO:0042981~regulation of apoptosis;GO:0051272~positive regulation of cell motion;GO:0030335~positive regulation of cell migration;GO:0043065~positive regulation of apoptosis;GO:0043067~regulation of programmed cell death;GO:0010942~positive regulation of cell death;GO:0030198~extracellular matrix organization;GO:0040012~regulation of locomotion;GO:0043068~positive regulation of programmed cell death;GO:0001501~skeletal system development;GO:0010941~regulation of cell death;GO:0032963~collagen metabolic process;GO:0043062~extracellular structure organization	GO:0005615~extracellular space;GO:0031012~extracellular matrix;GO:0005578~proteinaceous extracellular matrix;GO:0005576~extracellular region;GO:0044421~extracellular region part	GO:0005518~collagen binding;GO:0005509~calcium ion binding	IPR006025:Peptidase M, neutral zinc metallopeptidases, zinc-binding site;IPR001818:Peptidase M10A and M12B, matrixin and adamalysin	NA
SLC20A1	NA	GO:0005886~plasma membrane;GO:0031226~intrinsic to plasma membrane;GO:0005887~integral to plasma membrane;GO:0044459~plasma membrane part	NA	NA	NA
SGMS2	NA	GO:0005886~plasma membrane;GO:0031226~intrinsic to plasma membrane;GO:0005887~integral to plasma membrane;GO:0044459~plasma membrane part	NA	NA	NA
PTPRE	NA	GO:0005886~plasma membrane	GO:0046983~protein dimerization activity;GO:0042803~protein homodimerization activity	NA	NA
SLC7A1	NA	GO:0005886~plasma membrane;GO:0031226~intrinsic to plasma membrane;GO:0005887~integral to plasma membrane;GO:0044459~plasma membrane part	NA	NA	NA
SCARA5	GO:0050801~ion homeostasis;GO:0030003~cellular cation homeostasis;GO:0019725~cellular homeostasis;GO:0055080~cation homeostasis;GO:0009628~response to abiotic stimulus;GO:0055082~cellular chemical homeostasis;GO:0055066~di-, tri-valent inorganic cation homeostasis;GO:0048878~chemical homeostasis;GO:0030005~cellular di-, tri-valent inorganic cation homeostasis;GO:0006879~cellular iron ion homeostasis;GO:0042592~homeostatic process;GO:0006873~cellular ion homeostasis;GO:0055072~iron ion homeostasis;GO:0006826~iron ion transport	GO:0005886~plasma membrane;GO:0031226~intrinsic to plasma membrane;GO:0005887~integral to plasma membrane;GO:0009986~cell surface;GO:0044459~plasma membrane part	GO:0005044~scavenger receptor activity	IPR017448:Speract/scavenger receptor related;IPR001190:Speract/scavenger receptor	NA
CREB5	NA	NA	GO:0046983~protein dimerization activity;GO:0003700~transcription factor activity;GO:0043565~sequence-specific DNA binding	IPR004827:Basic-leucine zipper (bZIP) transcription factor;IPR011616:bZIP transcription factor, bZIP-1	NA
TUBA1C	GO:0051258~protein polymerization	NA	NA	NA	NA
CD44	GO:0010033~response to organic substance;GO:0033189~response to vitamin A;GO:0009611~response to wounding;GO:0042981~regulation of apoptosis;GO:0051674~localization of cell;GO:0001944~vasculature development;GO:0006928~cell motion;GO:0006952~defense response;GO:0014070~response to organic cyclic substance;GO:0002246~healing during inflammatory response;GO:0043065~positive regulation of apoptosis;GO:0043067~regulation of programmed cell death;GO:0010942~positive regulation of cell death;GO:0006954~inflammatory response;GO:0001568~blood vessel development;GO:0048870~cell motility;GO:0007584~response to nutrient;GO:0007155~cell adhesion;GO:0043068~positive regulation of programmed cell death;GO:0010941~regulation of cell death;GO:0016477~cell migration;GO:0033273~response to vitamin;GO:0031667~response to nutrient levels;GO:0040008~regulation of growth;GO:0042060~wound healing;GO:0001558~regulation of cell growth;GO:0009991~response to extracellular stimulus;GO:0022610~biological adhesion	GO:0005887~integral to plasma membrane;GO:0031012~extracellular matrix;GO:0005576~extracellular region;GO:0016323~basolateral plasma membrane;GO:0044459~plasma membrane part;GO:0031226~intrinsic to plasma membrane;GO:0005886~plasma membrane;GO:0044421~extracellular region part;GO:0009986~cell surface	GO:0005518~collagen binding;GO:0030246~carbohydrate binding;GO:0005539~glycosaminoglycan binding;GO:0005540~hyaluronic acid binding;GO:0030247~polysaccharide binding;GO:0001871~pattern binding	IPR016186:C-type lectin-like;IPR000538:Link	hsa04512:ECM-receptor interaction;hsa04640:Hematopoietic cell lineage
ZC3H12A	GO:0001944~vasculature development;GO:0012501~programmed cell death;GO:0008219~cell death;GO:0006915~apoptosis;GO:0016265~death;GO:0001525~angiogenesis;GO:0048514~blood vessel morphogenesis;GO:0001568~blood vessel development	NA	NA	NA	NA
GLIPR2	NA	GO:0005576~extracellular region	NA	NA	NA
S100A10	NA	NA	GO:0005509~calcium ion binding	NA	NA
ETS2	GO:0001501~skeletal system development	NA	GO:0003700~transcription factor activity;GO:0043565~sequence-specific DNA binding	NA	NA
CLEC3B	GO:0001501~skeletal system development	GO:0005576~extracellular region	GO:0030246~carbohydrate binding	IPR018378:C-type lectin, conserved site;IPR001304:C-type lectin;IPR016186:C-type lectin-like	NA
ACKR3	NA	GO:0005886~plasma membrane	NA	NA	NA
WISP2	GO:0040008~regulation of growth;GO:0007155~cell adhesion;GO:0008285~negative regulation of cell proliferation;GO:0001558~regulation of cell growth;GO:0042127~regulation of cell proliferation;GO:0022610~biological adhesion	GO:0005886~plasma membrane;GO:0009986~cell surface;GO:0005625~soluble fraction;GO:0005576~extracellular region	GO:0019838~growth factor binding;GO:0005520~insulin-like growth factor binding	IPR000867:Insulin-like growth factor-binding protein, IGFBP;IPR017891:Insulin-like growth factor binding protein, N-terminal;IPR000884:Thrombospondin, type 1 repeat	NA
LUM	GO:0043062~extracellular structure organization;GO:0030198~extracellular matrix organization	GO:0031012~extracellular matrix;GO:0005578~proteinaceous extracellular matrix;GO:0005576~extracellular region;GO:0044421~extracellular region part	GO:0005518~collagen binding	NA	NA
CTSL	NA	GO:0005625~soluble fraction;GO:0005576~extracellular region	GO:0042277~peptide binding	NA	NA
SH3BGRL3	GO:0019725~cellular homeostasis;GO:0042592~homeostatic process	NA	NA	NA	NA
DAP	GO:0012501~programmed cell death;GO:0042981~regulation of apoptosis;GO:0043068~positive regulation of programmed cell death;GO:0010941~regulation of cell death;GO:0008219~cell death;GO:0006915~apoptosis;GO:0016265~death;GO:0043067~regulation of programmed cell death;GO:0043065~positive regulation of apoptosis;GO:0010942~positive regulation of cell death	NA	NA	NA	NA
PKD1L1	GO:0007155~cell adhesion;GO:0022610~biological adhesion	NA	NA	NA	NA
UTY	NA	GO:0005730~nucleolus	NA	NA	NA
IFI16	GO:0008629~induction of apoptosis by intracellular signals;GO:0008283~cell proliferation;GO:0042981~regulation of apoptosis;GO:0008630~DNA damage response, signal transduction resulting in induction of apoptosis;GO:0043068~positive regulation of programmed cell death;GO:0010941~regulation of cell death;GO:0043067~regulation of programmed cell death;GO:0043065~positive regulation of apoptosis;GO:0010942~positive regulation of cell death	GO:0005730~nucleolus	NA	NA	NA
SELE	GO:0010033~response to organic substance;GO:0030029~actin filament-based process;GO:0050727~regulation of inflammatory response;GO:0050900~leukocyte migration;GO:0009611~response to wounding;GO:0007157~heterophilic cell adhesion;GO:0051674~localization of cell;GO:0034097~response to cytokine stimulus;GO:0006952~defense response;GO:0006928~cell motion;GO:0043085~positive regulation of catalytic activity;GO:0009617~response to bacterium;GO:0032496~response to lipopolysaccharide;GO:0006954~inflammatory response;GO:0048870~cell motility;GO:0007155~cell adhesion;GO:0016477~cell migration;GO:0032101~regulation of response to external stimulus;GO:0002237~response to molecule of bacterial origin;GO:0044093~positive regulation of molecular function;GO:0022610~biological adhesion	GO:0005886~plasma membrane;GO:0005615~extracellular space;GO:0045121~membrane raft;GO:0005576~extracellular region;GO:0044421~extracellular region part;GO:0044459~plasma membrane part	GO:0030246~carbohydrate binding	IPR000436:Sushi/SCR/CCP;IPR018378:C-type lectin, conserved site;IPR006210:EGF-like;IPR016186:C-type lectin-like;IPR000742:EGF-like, type 3;IPR013032:EGF-like region, conserved site;IPR006209:EGF;IPR016060:Complement control module;IPR001304:C-type lectin	NA
NFATC2	GO:0045944~positive regulation of transcription from RNA polymerase II promoter	NA	GO:0003700~transcription factor activity;GO:0043565~sequence-specific DNA binding	IPR000451:NF-kappa-B/Rel/dorsal;IPR011539:Rel homology;IPR013783:Immunoglobulin-like fold	hsa04010:MAPK signaling pathway
GAS7	GO:0030036~actin cytoskeleton organization;GO:0030029~actin filament-based process;GO:0008360~regulation of cell shape;GO:0007010~cytoskeleton organization;GO:0022604~regulation of cell morphogenesis;GO:0007015~actin filament organization;GO:0051258~protein polymerization	NA	GO:0003700~transcription factor activity	NA	NA
PER2	GO:0048511~rhythmic process	NA	NA	NA	NA
MSX1	GO:0010033~response to organic substance;GO:0043066~negative regulation of apoptosis;GO:0042981~regulation of apoptosis;GO:0007517~muscle organ development;GO:0010941~regulation of cell death;GO:0001501~skeletal system development;GO:0008285~negative regulation of cell proliferation;GO:0042127~regulation of cell proliferation;GO:0043067~regulation of programmed cell death;GO:0060548~negative regulation of cell death;GO:0043069~negative regulation of programmed cell death	NA	GO:0003700~transcription factor activity;GO:0043565~sequence-specific DNA binding	NA	NA
EMP3	GO:0032535~regulation of cellular component size;GO:0008285~negative regulation of cell proliferation;GO:0008361~regulation of cell size;GO:0042127~regulation of cell proliferation	NA	NA	NA	NA
CCND2	GO:0045859~regulation of protein kinase activity;GO:0010033~response to organic substance;GO:0048511~rhythmic process;GO:0051329~interphase of mitotic cell cycle;GO:0043627~response to estrogen stimulus;GO:0051591~response to cAMP;GO:0022403~cell cycle phase;GO:0048545~response to steroid hormone stimulus;GO:0000082~G1/S transition of mitotic cell cycle;GO:0042325~regulation of phosphorylation;GO:0000079~regulation of cyclin-dependent protein kinase activity;GO:0051347~positive regulation of transferase activity;GO:0051174~regulation of phosphorus metabolic process;GO:0014070~response to organic cyclic substance;GO:0045860~positive regulation of protein kinase activity;GO:0051338~regulation of transferase activity;GO:0043085~positive regulation of catalytic activity;GO:0051325~interphase;GO:0008284~positive regulation of cell proliferation;GO:0051726~regulation of cell cycle;GO:0009725~response to hormone stimulus;GO:0045787~positive regulation of cell cycle;GO:0019220~regulation of phosphate metabolic process;GO:0045737~positive regulation of cyclin-dependent protein kinase activity;GO:0044093~positive regulation of molecular function;GO:0009719~response to endogenous stimulus;GO:0042127~regulation of cell proliferation;GO:0043549~regulation of kinase activity;GO:0033674~positive regulation of kinase activity	GO:0000307~cyclin-dependent protein kinase holoenzyme complex	NA	NA	hsa04115:p53 signaling pathway
KCNQ3	NA	GO:0005886~plasma membrane;GO:0031226~intrinsic to plasma membrane;GO:0005887~integral to plasma membrane;GO:0044459~plasma membrane part	NA	NA	NA
S100A4	NA	GO:0005730~nucleolus	GO:0005509~calcium ion binding	NA	NA
DBN1	GO:0030036~actin cytoskeleton organization;GO:0030029~actin filament-based process;GO:0007010~cytoskeleton organization;GO:0031344~regulation of cell projection organization;GO:0007015~actin filament organization	NA	NA	NA	NA
PDLIM1	GO:0001666~response to hypoxia;GO:0070482~response to oxygen levels	NA	NA	NA	NA
SPTB	GO:0032535~regulation of cellular component size;GO:0043254~regulation of protein complex assembly;GO:0032271~regulation of protein polymerization	GO:0005886~plasma membrane;GO:0031226~intrinsic to plasma membrane;GO:0009986~cell surface;GO:0044459~plasma membrane part	NA	NA	NA
IL6	GO:0051270~regulation of cell motion;GO:0050727~regulation of inflammatory response;GO:0045944~positive regulation of transcription from RNA polymerase II promoter;GO:0002443~leukocyte mediated immunity;GO:0040017~positive regulation of locomotion;GO:0002252~immune effector process;GO:0009611~response to wounding;GO:0030334~regulation of cell migration;GO:0051272~positive regulation of cell motion;GO:0006953~acute-phase response;GO:0050829~defense response to Gram-negative bacterium;GO:0050878~regulation of body fluid levels;GO:0008219~cell death;GO:0051240~positive regulation of multicellular organismal process;GO:0042592~homeostatic process;GO:0016265~death;GO:0060548~negative regulation of cell death;GO:0051094~positive regulation of developmental process;GO:0001819~positive regulation of cytokine production;GO:0002675~positive regulation of acute inflammatory response;GO:0048545~response to steroid hormone stimulus;GO:0006959~humoral immune response;GO:0006935~chemotaxis;GO:0045765~regulation of angiogenesis;GO:0006915~apoptosis;GO:0050817~coagulation;GO:0050867~positive regulation of cell activation;GO:0048870~cell motility;GO:0007599~hemostasis;GO:0040012~regulation of locomotion;GO:0042060~wound healing;GO:0044093~positive regulation of molecular function;GO:0002684~positive regulation of immune system process;GO:0007626~locomotory behavior;GO:0006955~immune response;GO:0042981~regulation of apoptosis;GO:0060326~cell chemotaxis;GO:0050865~regulation of cell activation;GO:0051174~regulation of phosphorus metabolic process;GO:0001817~regulation of cytokine production;GO:0030335~positive regulation of cell migration;GO:0030595~leukocyte chemotaxis;GO:0045597~positive regulation of cell differentiation;GO:0043067~regulation of programmed cell death;GO:0008284~positive regulation of cell proliferation;GO:0012501~programmed cell death;GO:0043066~negative regulation of apoptosis;GO:0045727~positive regulation of translation;GO:0045669~positive regulation of osteoblast differentiation;GO:0008285~negative regulation of cell proliferation;GO:0043069~negative regulation of programmed cell death;GO:0010033~response to organic substance;GO:0050900~leukocyte migration;GO:0042325~regulation of phosphorylation;GO:0042330~taxis;GO:0051674~localization of cell;GO:0051384~response to glucocorticoid stimulus;GO:0006928~cell motion;GO:0006952~defense response;GO:0002526~acute inflammatory response;GO:0009617~response to bacterium;GO:0006954~inflammatory response;GO:0009725~response to hormone stimulus;GO:0032103~positive regulation of response to external stimulus;GO:0019220~regulation of phosphate metabolic process;GO:0010941~regulation of cell death;GO:0016477~cell migration;GO:0031960~response to corticosteroid stimulus;GO:0002548~monocyte chemotaxis;GO:0032101~regulation of response to external stimulus;GO:0002237~response to molecule of bacterial origin;GO:0048660~regulation of smooth muscle cell proliferation;GO:0009719~response to endogenous stimulus;GO:0042127~regulation of cell proliferation;GO:0007596~blood coagulation	GO:0005886~plasma membrane;GO:0031226~intrinsic to plasma membrane;GO:0005615~extracellular space;GO:0005887~integral to plasma membrane;GO:0005576~extracellular region;GO:0044421~extracellular region part;GO:0044459~plasma membrane part	GO:0008083~growth factor activity	NA	hsa04060:Cytokine-cytokine receptor interaction;hsa04640:Hematopoietic cell lineage
FAT3	GO:0007155~cell adhesion;GO:0022610~biological adhesion	NA	GO:0005509~calcium ion binding	IPR018097:EGF-like calcium-binding, conserved site;IPR013032:EGF-like region, conserved site;IPR006210:EGF-like;IPR006209:EGF;IPR001881:EGF-like calcium-binding;IPR000742:EGF-like, type 3	NA
PDPN	GO:0051270~regulation of cell motion;GO:0040017~positive regulation of locomotion;GO:0022604~regulation of cell morphogenesis;GO:0009611~response to wounding;GO:0030334~regulation of cell migration;GO:0051272~positive regulation of cell motion;GO:0001944~vasculature development;GO:0050865~regulation of cell activation;GO:0030335~positive regulation of cell migration;GO:0006952~defense response;GO:0050867~positive regulation of cell activation;GO:0006954~inflammatory response;GO:0008360~regulation of cell shape;GO:0007155~cell adhesion;GO:0008283~cell proliferation;GO:0040012~regulation of locomotion;GO:0006690~icosanoid metabolic process;GO:0032101~regulation of response to external stimulus;GO:0070482~response to oxygen levels;GO:0022610~biological adhesion	GO:0005886~plasma membrane;GO:0031226~intrinsic to plasma membrane;GO:0005887~integral to plasma membrane;GO:0044459~plasma membrane part	NA	NA	NA
ECM1	NA	GO:0031012~extracellular matrix;GO:0005578~proteinaceous extracellular matrix;GO:0005576~extracellular region;GO:0044421~extracellular region part	NA	NA	NA
CD276	GO:0008284~positive regulation of cell proliferation;GO:0050727~regulation of inflammatory response;GO:0008283~cell proliferation;GO:0006955~immune response;GO:0050865~regulation of cell activation;GO:0051240~positive regulation of multicellular organismal process;GO:0001817~regulation of cytokine production;GO:0045669~positive regulation of osteoblast differentiation;GO:0032101~regulation of response to external stimulus;GO:0008285~negative regulation of cell proliferation;GO:0050867~positive regulation of cell activation;GO:0042127~regulation of cell proliferation;GO:0045597~positive regulation of cell differentiation;GO:0051094~positive regulation of developmental process;GO:0002684~positive regulation of immune system process	GO:0005886~plasma membrane;GO:0009986~cell surface;GO:0044459~plasma membrane part	NA	IPR013783:Immunoglobulin-like fold;IPR003599:Immunoglobulin subtype	NA
MT1X	NA	NA	GO:0046870~cadmium ion binding	IPR000006:Metallothionein, vertebrate;IPR003019:Metallothionein superfamily, eukaryotic;IPR018064:Metallothionein, vertebrate, metal binding site	NA
TNC	GO:0007155~cell adhesion;GO:0043062~extracellular structure organization;GO:0009611~response to wounding;GO:0007517~muscle organ development;GO:0022610~biological adhesion	GO:0031012~extracellular matrix;GO:0005578~proteinaceous extracellular matrix;GO:0005576~extracellular region;GO:0044421~extracellular region part	NA	IPR013032:EGF-like region, conserved site;IPR006210:EGF-like;IPR006209:EGF;IPR008957:Fibronectin, type III-like fold;IPR003961:Fibronectin, type III;IPR000742:EGF-like, type 3	hsa04512:ECM-receptor interaction
SERPINA3	GO:0006953~acute-phase response;GO:0006952~defense response;GO:0042592~homeostatic process;GO:0002526~acute inflammatory response;GO:0009611~response to wounding;GO:0006954~inflammatory response	GO:0005576~extracellular region	NA	NA	NA
MT1M	NA	NA	GO:0046870~cadmium ion binding	IPR000006:Metallothionein, vertebrate;IPR003019:Metallothionein superfamily, eukaryotic;IPR018064:Metallothionein, vertebrate, metal binding site	NA
THBS4	GO:0016477~cell migration;GO:0007155~cell adhesion;GO:0006928~cell motion;GO:0006929~substrate-bound cell migration;GO:0022610~biological adhesion;GO:0048870~cell motility;GO:0051674~localization of cell	GO:0031093~platelet alpha granule lumen;GO:0031982~vesicle;GO:0030141~secretory granule;GO:0031012~extracellular matrix;GO:0031410~cytoplasmic vesicle;GO:0044433~cytoplasmic vesicle part;GO:0031988~membrane-bounded vesicle;GO:0005578~proteinaceous extracellular matrix;GO:0005576~extracellular region;GO:0031091~platelet alpha granule;GO:0031983~vesicle lumen;GO:0044421~extracellular region part;GO:0016023~cytoplasmic membrane-bounded vesicle;GO:0060205~cytoplasmic membrane-bounded vesicle lumen	GO:0030246~carbohydrate binding;GO:0005539~glycosaminoglycan binding;GO:0008201~heparin binding;GO:0030247~polysaccharide binding;GO:0001871~pattern binding;GO:0005509~calcium ion binding	IPR018097:EGF-like calcium-binding, conserved site;IPR013032:EGF-like region, conserved site;IPR006210:EGF-like;IPR013091:EGF calcium-binding;IPR001881:EGF-like calcium-binding;IPR000742:EGF-like, type 3	hsa04512:ECM-receptor interaction
MSR1	GO:0034381~lipoprotein particle clearance;GO:0045597~positive regulation of cell differentiation;GO:0051094~positive regulation of developmental process	GO:0034358~plasma lipoprotein particle;GO:0005887~integral to plasma membrane;GO:0005576~extracellular region;GO:0044459~plasma membrane part;GO:0005615~extracellular space;GO:0031226~intrinsic to plasma membrane;GO:0005886~plasma membrane;GO:0044421~extracellular region part;GO:0032994~protein-lipid complex	GO:0005044~scavenger receptor activity	IPR017448:Speract/scavenger receptor related;IPR001190:Speract/scavenger receptor	NA
SLC11A1	GO:0045944~positive regulation of transcription from RNA polymerase II promoter;GO:0002443~leukocyte mediated immunity;GO:0002252~immune effector process;GO:0006955~immune response;GO:0009611~response to wounding;GO:0002250~adaptive immune response;GO:0051347~positive regulation of transferase activity;GO:0034097~response to cytokine stimulus;GO:0001817~regulation of cytokine production;GO:0051174~regulation of phosphorus metabolic process;GO:0006873~cellular ion homeostasis;GO:0051338~regulation of transferase activity;GO:0050801~ion homeostasis;GO:0030003~cellular cation homeostasis;GO:0019725~cellular homeostasis;GO:0055080~cation homeostasis;GO:0008283~cell proliferation;GO:0055065~metal ion homeostasis;GO:0055066~di-, tri-valent inorganic cation homeostasis;GO:0002285~lymphocyte activation during immune response;GO:0030005~cellular di-, tri-valent inorganic cation homeostasis;GO:0050829~defense response to Gram-negative bacterium;GO:0006879~cellular iron ion homeostasis;GO:0051240~positive regulation of multicellular organismal process;GO:0002286~T cell activation during immune response;GO:0042592~homeostatic process;GO:0045087~innate immune response;GO:0006826~iron ion transport;GO:0001819~positive regulation of cytokine production;GO:0010033~response to organic substance;GO:0045859~regulation of protein kinase activity;GO:0002263~cell activation during immune response;GO:0042325~regulation of phosphorylation;GO:0006952~defense response;GO:0045860~positive regulation of protein kinase activity;GO:0043085~positive regulation of catalytic activity;GO:0055072~iron ion homeostasis;GO:0032496~response to lipopolysaccharide;GO:0009617~response to bacterium;GO:0006954~inflammatory response;GO:0006875~cellular metal ion homeostasis;GO:0055082~cellular chemical homeostasis;GO:0002366~leukocyte activation during immune response;GO:0048878~chemical homeostasis;GO:0019220~regulation of phosphate metabolic process;GO:0042060~wound healing;GO:0002237~response to molecule of bacterial origin;GO:0044093~positive regulation of molecular function;GO:0043549~regulation of kinase activity;GO:0002460~adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains;GO:0033674~positive regulation of kinase activity;GO:0002684~positive regulation of immune system process	GO:0031982~vesicle;GO:0030141~secretory granule;GO:0005887~integral to plasma membrane;GO:0031410~cytoplasmic vesicle;GO:0044433~cytoplasmic vesicle part;GO:0031988~membrane-bounded vesicle;GO:0044459~plasma membrane part;GO:0031226~intrinsic to plasma membrane;GO:0005886~plasma membrane;GO:0016023~cytoplasmic membrane-bounded vesicle	GO:0046983~protein dimerization activity;GO:0042803~protein homodimerization activity	NA	NA
TSC22D2	NA	NA	GO:0003700~transcription factor activity	NA	NA
SPOCK2	GO:0043062~extracellular structure organization;GO:0030198~extracellular matrix organization	GO:0031012~extracellular matrix;GO:0005578~proteinaceous extracellular matrix;GO:0005576~extracellular region;GO:0044421~extracellular region part	GO:0005509~calcium ion binding	NA	NA
LRRC32	NA	GO:0005886~plasma membrane;GO:0031226~intrinsic to plasma membrane;GO:0005887~integral to plasma membrane;GO:0044459~plasma membrane part	NA	NA	NA
PCDH12	GO:0007155~cell adhesion;GO:0022610~biological adhesion	GO:0005886~plasma membrane;GO:0031226~intrinsic to plasma membrane;GO:0005887~integral to plasma membrane;GO:0044459~plasma membrane part	GO:0005509~calcium ion binding	NA	NA
SCARA3	GO:0009314~response to radiation;GO:0009628~response to abiotic stimulus;GO:0009411~response to UV	NA	GO:0005044~scavenger receptor activity	NA	NA
VASN	NA	GO:0005576~extracellular region	NA	IPR013032:EGF-like region, conserved site;IPR006210:EGF-like;IPR006209:EGF;IPR003961:Fibronectin, type III;IPR000742:EGF-like, type 3	NA
MT2A	GO:0050801~ion homeostasis;GO:0030003~cellular cation homeostasis;GO:0019725~cellular homeostasis;GO:0055080~cation homeostasis;GO:0055082~cellular chemical homeostasis;GO:0055066~di-, tri-valent inorganic cation homeostasis;GO:0048878~chemical homeostasis;GO:0030005~cellular di-, tri-valent inorganic cation homeostasis;GO:0042592~homeostatic process;GO:0006873~cellular ion homeostasis	NA	NA	IPR000006:Metallothionein, vertebrate;IPR003019:Metallothionein superfamily, eukaryotic;IPR018064:Metallothionein, vertebrate, metal binding site	NA
HIF1A	GO:0051270~regulation of cell motion;GO:0045944~positive regulation of transcription from RNA polymerase II promoter;GO:0044236~multicellular organismal metabolic process;GO:0040017~positive regulation of locomotion;GO:0009611~response to wounding;GO:0030334~regulation of cell migration;GO:0051272~positive regulation of cell motion;GO:0001666~response to hypoxia;GO:0001944~vasculature development;GO:0030335~positive regulation of cell migration;GO:0001817~regulation of cytokine production;GO:0002246~healing during inflammatory response;GO:0045597~positive regulation of cell differentiation;GO:0001568~blood vessel development;GO:0008284~positive regulation of cell proliferation;GO:0019725~cellular homeostasis;GO:0048568~embryonic organ development;GO:0001525~angiogenesis;GO:0048514~blood vessel morphogenesis;GO:0051240~positive regulation of multicellular organismal process;GO:0042592~homeostatic process;GO:0032963~collagen metabolic process;GO:0070482~response to oxygen levels;GO:0051094~positive regulation of developmental process;GO:0001819~positive regulation of cytokine production;GO:0001890~placenta development;GO:0051674~localization of cell;GO:0045765~regulation of angiogenesis;GO:0006952~defense response;GO:0006928~cell motion;GO:0043085~positive regulation of catalytic activity;GO:0006954~inflammatory response;GO:0048870~cell motility;GO:0051353~positive regulation of oxidoreductase activity;GO:0045766~positive regulation of angiogenesis;GO:0048878~chemical homeostasis;GO:0040012~regulation of locomotion;GO:0016477~cell migration;GO:0042060~wound healing;GO:0044093~positive regulation of molecular function;GO:0042127~regulation of cell proliferation	GO:0005730~nucleolus	GO:0046983~protein dimerization activity;GO:0003700~transcription factor activity;GO:0043565~sequence-specific DNA binding	NA	NA
BDKRB2	GO:0009611~response to wounding;GO:0042981~regulation of apoptosis;GO:0051174~regulation of phosphorus metabolic process;GO:0006873~cellular ion homeostasis;GO:0043067~regulation of programmed cell death;GO:0006874~cellular calcium ion homeostasis;GO:0050801~ion homeostasis;GO:0030003~cellular cation homeostasis;GO:0019725~cellular homeostasis;GO:0055080~cation homeostasis;GO:0055065~metal ion homeostasis;GO:0055066~di-, tri-valent inorganic cation homeostasis;GO:0043066~negative regulation of apoptosis;GO:0030005~cellular di-, tri-valent inorganic cation homeostasis;GO:0003013~circulatory system process;GO:0042592~homeostatic process;GO:0008285~negative regulation of cell proliferation;GO:0060548~negative regulation of cell death;GO:0043069~negative regulation of programmed cell death;GO:0042325~regulation of phosphorylation;GO:0006952~defense response;GO:0006954~inflammatory response;GO:0006875~cellular metal ion homeostasis;GO:0055074~calcium ion homeostasis;GO:0008015~blood circulation;GO:0055082~cellular chemical homeostasis;GO:0009628~response to abiotic stimulus;GO:0007204~elevation of cytosolic calcium ion concentration;GO:0048878~chemical homeostasis;GO:0019220~regulation of phosphate metabolic process;GO:0010941~regulation of cell death;GO:0042127~regulation of cell proliferation	GO:0005886~plasma membrane;GO:0031226~intrinsic to plasma membrane;GO:0005887~integral to plasma membrane;GO:0044459~plasma membrane part	GO:0046983~protein dimerization activity;GO:0008528~peptide receptor activity, G-protein coupled;GO:0042277~peptide binding;GO:0001653~peptide receptor activity	NA	hsa04610:Complement and coagulation cascades
TUBB3	GO:0009314~response to radiation;GO:0009628~response to abiotic stimulus;GO:0022403~cell cycle phase;GO:0009411~response to UV;GO:0051258~protein polymerization	GO:0005886~plasma membrane;GO:0031226~intrinsic to plasma membrane;GO:0005887~integral to plasma membrane;GO:0044459~plasma membrane part	GO:0008528~peptide receptor activity, G-protein coupled;GO:0042277~peptide binding;GO:0001653~peptide receptor activity	NA	NA
TXN	GO:0019725~cellular homeostasis;GO:0006928~cell motion;GO:0042592~homeostatic process;GO:0008283~cell proliferation	NA	NA	NA	NA
GYG2	GO:0016051~carbohydrate biosynthetic process;GO:0000271~polysaccharide biosynthetic process;GO:0034637~cellular carbohydrate biosynthetic process	GO:0005625~soluble fraction	GO:0035251~UDP-glucosyltransferase activity;GO:0046527~glucosyltransferase activity	NA	NA
CCL2	GO:0009314~response to radiation;GO:0009611~response to wounding;GO:0001666~response to hypoxia;GO:0050801~ion homeostasis;GO:0030003~cellular cation homeostasis;GO:0019725~cellular homeostasis;GO:0055065~metal ion homeostasis;GO:0051240~positive regulation of multicellular organismal process;GO:0042592~homeostatic process;GO:0009991~response to extracellular stimulus;GO:0060548~negative regulation of cell death;GO:0070482~response to oxygen levels;GO:0048545~response to steroid hormone stimulus;GO:0006959~humoral immune response;GO:0006935~chemotaxis;GO:0055074~calcium ion homeostasis;GO:0048870~cell motility;GO:0010212~response to ionizing radiation;GO:0007584~response to nutrient;GO:0055082~cellular chemical homeostasis;GO:0048878~chemical homeostasis;GO:0031099~regeneration;GO:0042493~response to drug;GO:0048246~macrophage chemotaxis;GO:0007626~locomotory behavior;GO:0006955~immune response;GO:0042981~regulation of apoptosis;GO:0060326~cell chemotaxis;GO:0030595~leukocyte chemotaxis;GO:0006873~cellular ion homeostasis;GO:0043067~regulation of programmed cell death;GO:0008284~positive regulation of cell proliferation;GO:0006874~cellular calcium ion homeostasis;GO:0007155~cell adhesion;GO:0055080~cation homeostasis;GO:0055066~di-, tri-valent inorganic cation homeostasis;GO:0043066~negative regulation of apoptosis;GO:0030005~cellular di-, tri-valent inorganic cation homeostasis;GO:0033273~response to vitamin;GO:0031667~response to nutrient levels;GO:0043069~negative regulation of programmed cell death;GO:0010033~response to organic substance;GO:0050900~leukocyte migration;GO:0042330~taxis;GO:0051674~localization of cell;GO:0051384~response to glucocorticoid stimulus;GO:0006928~cell motion;GO:0006952~defense response;GO:0032496~response to lipopolysaccharide;GO:0009617~response to bacterium;GO:0032570~response to progesterone stimulus;GO:0006954~inflammatory response;GO:0006875~cellular metal ion homeostasis;GO:0009725~response to hormone stimulus;GO:0009628~response to abiotic stimulus;GO:0031100~organ regeneration;GO:0010941~regulation of cell death;GO:0016477~cell migration;GO:0002548~monocyte chemotaxis;GO:0031960~response to corticosteroid stimulus;GO:0002237~response to molecule of bacterial origin;GO:0009719~response to endogenous stimulus;GO:0042127~regulation of cell proliferation;GO:0022610~biological adhesion	GO:0005615~extracellular space;GO:0005576~extracellular region;GO:0044421~extracellular region part	GO:0030246~carbohydrate binding;GO:0005539~glycosaminoglycan binding;GO:0008201~heparin binding;GO:0030247~polysaccharide binding;GO:0001871~pattern binding	NA	hsa04060:Cytokine-cytokine receptor interaction
ITPRIP	NA	GO:0005886~plasma membrane	NA	NA	NA
ITGA11	GO:0007155~cell adhesion;GO:0006929~substrate-bound cell migration;GO:0007517~muscle organ development;GO:0051674~localization of cell;GO:0016477~cell migration;GO:0006928~cell motion;GO:0048870~cell motility;GO:0022610~biological adhesion	GO:0005886~plasma membrane;GO:0031226~intrinsic to plasma membrane;GO:0005887~integral to plasma membrane;GO:0044459~plasma membrane part	GO:0005518~collagen binding;GO:0005509~calcium ion binding	NA	hsa04512:ECM-receptor interaction
RELT	NA	GO:0005886~plasma membrane	NA	NA	hsa04060:Cytokine-cytokine receptor interaction
XYLT1	GO:0016051~carbohydrate biosynthetic process;GO:0009628~response to abiotic stimulus;GO:0000271~polysaccharide biosynthetic process	GO:0005576~extracellular region	GO:0016763~transferase activity, transferring pentosyl groups	NA	NA
ACVR2B	GO:0045859~regulation of protein kinase activity;GO:0010033~response to organic substance;GO:0042325~regulation of phosphorylation;GO:0051347~positive regulation of transferase activity;GO:0051174~regulation of phosphorus metabolic process;GO:0009791~post-embryonic development;GO:0045860~positive regulation of protein kinase activity;GO:0051338~regulation of transferase activity;GO:0043085~positive regulation of catalytic activity;GO:0045597~positive regulation of cell differentiation;GO:0019220~regulation of phosphate metabolic process;GO:0048705~skeletal system morphogenesis;GO:0001501~skeletal system development;GO:0051240~positive regulation of multicellular organismal process;GO:0045669~positive regulation of osteoblast differentiation;GO:0044093~positive regulation of molecular function;GO:0043549~regulation of kinase activity;GO:0051094~positive regulation of developmental process;GO:0033674~positive regulation of kinase activity	GO:0005886~plasma membrane;GO:0031226~intrinsic to plasma membrane;GO:0005887~integral to plasma membrane;GO:0009986~cell surface;GO:0044459~plasma membrane part	GO:0032403~protein complex binding;GO:0019838~growth factor binding	NA	hsa04060:Cytokine-cytokine receptor interaction
EFHD2	NA	GO:0045121~membrane raft	GO:0005509~calcium ion binding	NA	NA
UCHL1	GO:0007626~locomotory behavior;GO:0008283~cell proliferation	GO:0005730~nucleolus	NA	NA	NA
VDR	GO:0042981~regulation of apoptosis;GO:0006873~cellular ion homeostasis;GO:0043065~positive regulation of apoptosis;GO:0043067~regulation of programmed cell death;GO:0006874~cellular calcium ion homeostasis;GO:0050801~ion homeostasis;GO:0030003~cellular cation homeostasis;GO:0001893~maternal placenta development;GO:0019725~cellular homeostasis;GO:0055080~cation homeostasis;GO:0055065~metal ion homeostasis;GO:0055066~di-, tri-valent inorganic cation homeostasis;GO:0031668~cellular response to extracellular stimulus;GO:0030005~cellular di-, tri-valent inorganic cation homeostasis;GO:0001501~skeletal system development;GO:0033273~response to vitamin;GO:0031667~response to nutrient levels;GO:0042592~homeostatic process;GO:0008285~negative regulation of cell proliferation;GO:0009991~response to extracellular stimulus;GO:0001890~placenta development;GO:0007565~female pregnancy;GO:0043085~positive regulation of catalytic activity;GO:0010942~positive regulation of cell death;GO:0006875~cellular metal ion homeostasis;GO:0055074~calcium ion homeostasis;GO:0007584~response to nutrient;GO:0051353~positive regulation of oxidoreductase activity;GO:0055082~cellular chemical homeostasis;GO:0048878~chemical homeostasis;GO:0043068~positive regulation of programmed cell death;GO:0010941~regulation of cell death;GO:0046697~decidualization;GO:0044093~positive regulation of molecular function;GO:0042127~regulation of cell proliferation	NA	GO:0003700~transcription factor activity;GO:0043565~sequence-specific DNA binding	NA	NA
TNNC1	GO:0008015~blood circulation;GO:0003013~circulatory system process;GO:0007517~muscle organ development	GO:0030016~myofibril	GO:0046983~protein dimerization activity;GO:0042803~protein homodimerization activity;GO:0005509~calcium ion binding	NA	NA
CADM3	GO:0007155~cell adhesion;GO:0007157~heterophilic cell adhesion;GO:0022610~biological adhesion	GO:0005886~plasma membrane;GO:0044459~plasma membrane part	GO:0046983~protein dimerization activity;GO:0042803~protein homodimerization activity;GO:0005509~calcium ion binding	IPR013783:Immunoglobulin-like fold;IPR003599:Immunoglobulin subtype	NA
ABI3BP	NA	NA	NA	IPR008957:Fibronectin, type III-like fold;IPR003961:Fibronectin, type III	NA
HBEGF	GO:0051270~regulation of cell motion;GO:0040017~positive regulation of locomotion;GO:0009611~response to wounding;GO:0030334~regulation of cell migration;GO:0051272~positive regulation of cell motion;GO:0051674~localization of cell;GO:0045793~positive regulation of cell size;GO:0030335~positive regulation of cell migration;GO:0006928~cell motion;GO:0008361~regulation of cell size;GO:0048870~cell motility;GO:0008284~positive regulation of cell proliferation;GO:0030307~positive regulation of cell growth;GO:0007517~muscle organ development;GO:0040012~regulation of locomotion;GO:0016477~cell migration;GO:0032535~regulation of cellular component size;GO:0040008~regulation of growth;GO:0042060~wound healing;GO:0048660~regulation of smooth muscle cell proliferation;GO:0001558~regulation of cell growth;GO:0042127~regulation of cell proliferation	GO:0005887~integral to plasma membrane;GO:0005576~extracellular region;GO:0044459~plasma membrane part;GO:0005615~extracellular space;GO:0031226~intrinsic to plasma membrane;GO:0005886~plasma membrane;GO:0044421~extracellular region part;GO:0009986~cell surface	GO:0030246~carbohydrate binding;GO:0008083~growth factor activity;GO:0005539~glycosaminoglycan binding;GO:0008201~heparin binding;GO:0030247~polysaccharide binding;GO:0001871~pattern binding	IPR013032:EGF-like region, conserved site;IPR006210:EGF-like;IPR006209:EGF;IPR000742:EGF-like, type 3	hsa04012:ErbB signaling pathway
CHST3	GO:0051270~regulation of cell motion;GO:0031099~regeneration;GO:0016051~carbohydrate biosynthetic process;GO:0000271~polysaccharide biosynthetic process;GO:0009611~response to wounding;GO:0051272~positive regulation of cell motion	NA	NA	NA	NA
FADS1	GO:0007584~response to nutrient;GO:0010033~response to organic substance;GO:0009725~response to hormone stimulus;GO:0033189~response to vitamin A;GO:0046394~carboxylic acid biosynthetic process;GO:0031668~cellular response to extracellular stimulus;GO:0016053~organic acid biosynthetic process;GO:0033273~response to vitamin;GO:0031667~response to nutrient levels;GO:0006690~icosanoid metabolic process;GO:0014070~response to organic cyclic substance;GO:0009719~response to endogenous stimulus;GO:0009991~response to extracellular stimulus	NA	NA	NA	NA
LPIN1	GO:0010033~response to organic substance;GO:0030036~actin cytoskeleton organization;GO:0030029~actin filament-based process;GO:0007010~cytoskeleton organization;GO:0009725~response to hormone stimulus;GO:0009719~response to endogenous stimulus	NA	NA	NA	NA
SLC19A2	NA	GO:0005886~plasma membrane	NA	NA	NA
THY1	GO:0051270~regulation of cell motion;GO:0031344~regulation of cell projection organization;GO:0022604~regulation of cell morphogenesis;GO:0030334~regulation of cell migration;GO:0006469~negative regulation of protein kinase activity;GO:0001944~vasculature development;GO:0050865~regulation of cell activation;GO:0051174~regulation of phosphorus metabolic process;GO:0051338~regulation of transferase activity;GO:0033673~negative regulation of kinase activity;GO:0001568~blood vessel development;GO:0007155~cell adhesion;GO:0001525~angiogenesis;GO:0048514~blood vessel morphogenesis;GO:0040013~negative regulation of locomotion;GO:0030336~negative regulation of cell migration;GO:0009968~negative regulation of signal transduction;GO:0045859~regulation of protein kinase activity;GO:0007010~cytoskeleton organization;GO:0051348~negative regulation of transferase activity;GO:0042325~regulation of phosphorylation;GO:0043085~positive regulation of catalytic activity;GO:0050867~positive regulation of cell activation;GO:0051271~negative regulation of cell motion;GO:0045596~negative regulation of cell differentiation;GO:0019220~regulation of phosphate metabolic process;GO:0040012~regulation of locomotion;GO:0044093~positive regulation of molecular function;GO:0034329~cell junction assembly;GO:0043549~regulation of kinase activity;GO:0022610~biological adhesion;GO:0002684~positive regulation of immune system process	GO:0005886~plasma membrane;GO:0031226~intrinsic to plasma membrane;GO:0005887~integral to plasma membrane;GO:0009986~cell surface;GO:0045121~membrane raft;GO:0044459~plasma membrane part	GO:0032403~protein complex binding;GO:0005178~integrin binding	IPR003599:Immunoglobulin subtype	NA
PCLO	GO:0007010~cytoskeleton organization	GO:0005886~plasma membrane;GO:0031982~vesicle;GO:0031410~cytoplasmic vesicle;GO:0031988~membrane-bounded vesicle;GO:0016023~cytoplasmic membrane-bounded vesicle;GO:0044459~plasma membrane part	GO:0005509~calcium ion binding	NA	NA
GALNT12	NA	NA	GO:0030246~carbohydrate binding;GO:0005509~calcium ion binding	IPR001173:Glycosyl transferase, family 2	NA
FOSL2	GO:0008284~positive regulation of cell proliferation;GO:0008219~cell death;GO:0048146~positive regulation of fibroblast proliferation;GO:0016265~death;GO:0042127~regulation of cell proliferation	GO:0005730~nucleolus	GO:0046983~protein dimerization activity;GO:0003700~transcription factor activity;GO:0043565~sequence-specific DNA binding	IPR004827:Basic-leucine zipper (bZIP) transcription factor;IPR011616:bZIP transcription factor, bZIP-1;IPR000837:Fos transforming protein	NA
NABP1	GO:0010212~response to ionizing radiation;GO:0051726~regulation of cell cycle;GO:0009314~response to radiation;GO:0009628~response to abiotic stimulus	NA	NA	NA	NA
LDLR	GO:0010033~response to organic substance;GO:0009725~response to hormone stimulus;GO:0043627~response to estrogen stimulus;GO:0048545~response to steroid hormone stimulus;GO:0048878~chemical homeostasis;GO:0034381~lipoprotein particle clearance;GO:0042592~homeostatic process;GO:0034383~low-density lipoprotein particle clearance;GO:0009719~response to endogenous stimulus	GO:0034358~plasma lipoprotein particle;GO:0031982~vesicle;GO:0005887~integral to plasma membrane;GO:0031410~cytoplasmic vesicle;GO:0045121~membrane raft;GO:0044433~cytoplasmic vesicle part;GO:0031988~membrane-bounded vesicle;GO:0005576~extracellular region;GO:0044459~plasma membrane part;GO:0005615~extracellular space;GO:0031226~intrinsic to plasma membrane;GO:0005886~plasma membrane;GO:0044421~extracellular region part;GO:0016023~cytoplasmic membrane-bounded vesicle;GO:0032994~protein-lipid complex	GO:0005509~calcium ion binding	IPR018097:EGF-like calcium-binding, conserved site;IPR013032:EGF-like region, conserved site;IPR006210:EGF-like;IPR006209:EGF;IPR013091:EGF calcium-binding;IPR001881:EGF-like calcium-binding;IPR000742:EGF-like, type 3	NA
CSRNP1	GO:0060325~face morphogenesis;GO:0045944~positive regulation of transcription from RNA polymerase II promoter;GO:0012501~programmed cell death;GO:0060323~head morphogenesis;GO:0048705~skeletal system morphogenesis;GO:0001501~skeletal system development;GO:0008219~cell death;GO:0009791~post-embryonic development;GO:0006915~apoptosis;GO:0060324~face development;GO:0016265~death	NA	GO:0003700~transcription factor activity	NA	NA
CA12	NA	GO:0005886~plasma membrane	NA	NA	NA
CXCL2	GO:0006952~defense response;GO:0007626~locomotory behavior;GO:0006955~immune response;GO:0009611~response to wounding;GO:0042330~taxis;GO:0006935~chemotaxis;GO:0006954~inflammatory response	GO:0005615~extracellular space;GO:0005625~soluble fraction;GO:0005576~extracellular region;GO:0044421~extracellular region part	NA	NA	hsa04060:Cytokine-cytokine receptor interaction
NTRK3	GO:0045773~positive regulation of axon extension;GO:0030307~positive regulation of cell growth;GO:0031344~regulation of cell projection organization;GO:0032103~positive regulation of response to external stimulus;GO:0022604~regulation of cell morphogenesis;GO:0032535~regulation of cellular component size;GO:0045793~positive regulation of cell size;GO:0040008~regulation of growth;GO:0032101~regulation of response to external stimulus;GO:0031346~positive regulation of cell projection organization;GO:0001558~regulation of cell growth;GO:0008361~regulation of cell size;GO:0045597~positive regulation of cell differentiation;GO:0051094~positive regulation of developmental process	GO:0005886~plasma membrane;GO:0031226~intrinsic to plasma membrane;GO:0005887~integral to plasma membrane;GO:0044459~plasma membrane part	GO:0019838~growth factor binding	IPR013783:Immunoglobulin-like fold;IPR003599:Immunoglobulin subtype	NA
GJC1	GO:0001944~vasculature development;GO:0034329~cell junction assembly;GO:0048514~blood vessel morphogenesis;GO:0007517~muscle organ development;GO:0001568~blood vessel development	GO:0005886~plasma membrane;GO:0044459~plasma membrane part	NA	NA	NA
OSGIN1	GO:0032535~regulation of cellular component size;GO:0040008~regulation of growth;GO:0008361~regulation of cell size;GO:0001558~regulation of cell growth	NA	GO:0008083~growth factor activity	NA	NA
MAP2K3	GO:0045859~regulation of protein kinase activity;GO:0009611~response to wounding;GO:0042325~regulation of phosphorylation;GO:0051347~positive regulation of transferase activity;GO:0001817~regulation of cytokine production;GO:0006952~defense response;GO:0051174~regulation of phosphorus metabolic process;GO:0045860~positive regulation of protein kinase activity;GO:0051338~regulation of transferase activity;GO:0043085~positive regulation of catalytic activity;GO:0006954~inflammatory response;GO:0008015~blood circulation;GO:0019220~regulation of phosphate metabolic process;GO:0003013~circulatory system process;GO:0044093~positive regulation of molecular function;GO:0043549~regulation of kinase activity;GO:0033674~positive regulation of kinase activity	NA	NA	NA	hsa04010:MAPK signaling pathway
CECR2	GO:0030262~apoptotic nuclear changes;GO:0007010~cytoskeleton organization;GO:0012501~programmed cell death;GO:0008219~cell death;GO:0006915~apoptosis;GO:0016265~death	NA	NA	NA	NA
ODC1	GO:0008284~positive regulation of cell proliferation;GO:0042127~regulation of cell proliferation	NA	NA	NA	NA
ANGPTL4	GO:0001525~angiogenesis;GO:0043066~negative regulation of apoptosis;GO:0048514~blood vessel morphogenesis;GO:0045766~positive regulation of angiogenesis;GO:0042981~regulation of apoptosis;GO:0045765~regulation of angiogenesis;GO:0010941~regulation of cell death;GO:0001944~vasculature development;GO:0001666~response to hypoxia;GO:0043067~regulation of programmed cell death;GO:0060548~negative regulation of cell death;GO:0070482~response to oxygen levels;GO:0051094~positive regulation of developmental process;GO:0043069~negative regulation of programmed cell death;GO:0001568~blood vessel development	GO:0005615~extracellular space;GO:0031012~extracellular matrix;GO:0005578~proteinaceous extracellular matrix;GO:0005576~extracellular region;GO:0044421~extracellular region part	NA	NA	NA
BHLHE40	NA	NA	GO:0003700~transcription factor activity	NA	NA
LIF	GO:0045944~positive regulation of transcription from RNA polymerase II promoter;GO:0048864~stem cell development;GO:0001890~placenta development;GO:0019827~stem cell maintenance;GO:0006955~immune response;GO:0042325~regulation of phosphorylation;GO:0051174~regulation of phosphorus metabolic process;GO:0007565~female pregnancy;GO:0045597~positive regulation of cell differentiation;GO:0008284~positive regulation of cell proliferation;GO:0001893~maternal placenta development;GO:0051726~regulation of cell cycle;GO:0045596~negative regulation of cell differentiation;GO:0019220~regulation of phosphate metabolic process;GO:0031100~organ regeneration;GO:0007517~muscle organ development;GO:0031099~regeneration;GO:0046697~decidualization;GO:0042127~regulation of cell proliferation;GO:0051094~positive regulation of developmental process	GO:0005615~extracellular space;GO:0005576~extracellular region;GO:0044421~extracellular region part	GO:0008083~growth factor activity	NA	hsa04060:Cytokine-cytokine receptor interaction
SLC7A5	NA	GO:0005886~plasma membrane	GO:0042277~peptide binding	NA	NA
CCL13	GO:0007626~locomotory behavior;GO:0006955~immune response;GO:0009611~response to wounding;GO:0042330~taxis;GO:0006935~chemotaxis;GO:0006952~defense response;GO:0006873~cellular ion homeostasis;GO:0055074~calcium ion homeostasis;GO:0006875~cellular metal ion homeostasis;GO:0006954~inflammatory response;GO:0006874~cellular calcium ion homeostasis;GO:0030003~cellular cation homeostasis;GO:0050801~ion homeostasis;GO:0055080~cation homeostasis;GO:0019725~cellular homeostasis;GO:0055082~cellular chemical homeostasis;GO:0055065~metal ion homeostasis;GO:0055066~di-, tri-valent inorganic cation homeostasis;GO:0030005~cellular di-, tri-valent inorganic cation homeostasis;GO:0048878~chemical homeostasis;GO:0042592~homeostatic process	GO:0005615~extracellular space;GO:0005576~extracellular region;GO:0044421~extracellular region part	NA	NA	hsa04060:Cytokine-cytokine receptor interaction
IER3	GO:0012501~programmed cell death;GO:0043066~negative regulation of apoptosis;GO:0042981~regulation of apoptosis;GO:0010941~regulation of cell death;GO:0008219~cell death;GO:0006915~apoptosis;GO:0016265~death;GO:0043067~regulation of programmed cell death;GO:0060548~negative regulation of cell death;GO:0043069~negative regulation of programmed cell death	NA	NA	NA	NA
SPP1	GO:0010033~response to organic substance;GO:0031344~regulation of cell projection organization;GO:0001890~placenta development;GO:0022604~regulation of cell morphogenesis;GO:0048545~response to steroid hormone stimulus;GO:0009611~response to wounding;GO:0006952~defense response;GO:0007565~female pregnancy;GO:0008361~regulation of cell size;GO:0006954~inflammatory response;GO:0007584~response to nutrient;GO:0001893~maternal placenta development;GO:0009725~response to hormone stimulus;GO:0007155~cell adhesion;GO:0045596~negative regulation of cell differentiation;GO:0032535~regulation of cellular component size;GO:0033273~response to vitamin;GO:0046697~decidualization;GO:0001501~skeletal system development;GO:0031667~response to nutrient levels;GO:0040008~regulation of growth;GO:0051240~positive regulation of multicellular organismal process;GO:0032101~regulation of response to external stimulus;GO:0009719~response to endogenous stimulus;GO:0001558~regulation of cell growth;GO:0009991~response to extracellular stimulus;GO:0022610~biological adhesion	GO:0005615~extracellular space;GO:0031982~vesicle;GO:0031988~membrane-bounded vesicle;GO:0005576~extracellular region;GO:0044421~extracellular region part	NA	NA	hsa04512:ECM-receptor interaction
F5	GO:0008015~blood circulation;GO:0007599~hemostasis;GO:0007155~cell adhesion;GO:0009611~response to wounding;GO:0050878~regulation of body fluid levels;GO:0042060~wound healing;GO:0003013~circulatory system process;GO:0050817~coagulation;GO:0022610~biological adhesion;GO:0007596~blood coagulation	GO:0031093~platelet alpha granule lumen;GO:0031982~vesicle;GO:0030141~secretory granule;GO:0031410~cytoplasmic vesicle;GO:0044433~cytoplasmic vesicle part;GO:0031988~membrane-bounded vesicle;GO:0005576~extracellular region;GO:0031091~platelet alpha granule;GO:0031983~vesicle lumen;GO:0005615~extracellular space;GO:0005886~plasma membrane;GO:0044421~extracellular region part;GO:0016023~cytoplasmic membrane-bounded vesicle;GO:0060205~cytoplasmic membrane-bounded vesicle lumen	GO:0005509~calcium ion binding	NA	hsa04610:Complement and coagulation cascades
XAF1	GO:0012501~programmed cell death;GO:0008219~cell death;GO:0006915~apoptosis;GO:0016265~death	NA	NA	NA	NA
GPRC5A	NA	GO:0005886~plasma membrane;GO:0031226~intrinsic to plasma membrane;GO:0031982~vesicle;GO:0005887~integral to plasma membrane;GO:0031410~cytoplasmic vesicle;GO:0044459~plasma membrane part	NA	NA	NA
SRGN	GO:0012501~programmed cell death;GO:0008219~cell death;GO:0001817~regulation of cytokine production;GO:0006915~apoptosis;GO:0016265~death	GO:0031093~platelet alpha granule lumen;GO:0031982~vesicle;GO:0030141~secretory granule;GO:0031410~cytoplasmic vesicle;GO:0044433~cytoplasmic vesicle part;GO:0031988~membrane-bounded vesicle;GO:0005576~extracellular region;GO:0031091~platelet alpha granule;GO:0031983~vesicle lumen;GO:0005615~extracellular space;GO:0044421~extracellular region part;GO:0016023~cytoplasmic membrane-bounded vesicle;GO:0060205~cytoplasmic membrane-bounded vesicle lumen	NA	NA	NA
NRG2	NA	GO:0005886~plasma membrane;GO:0005576~extracellular region	GO:0008083~growth factor activity	IPR013032:EGF-like region, conserved site;IPR006210:EGF-like;IPR006209:EGF;IPR013783:Immunoglobulin-like fold;IPR000742:EGF-like, type 3	hsa04012:ErbB signaling pathway
CCRN4L	GO:0048511~rhythmic process	NA	GO:0003700~transcription factor activity	NA	NA
TRIB1	GO:0045859~regulation of protein kinase activity;GO:0051270~regulation of cell motion;GO:0010033~response to organic substance;GO:0051348~negative regulation of transferase activity;GO:0030334~regulation of cell migration;GO:0042325~regulation of phosphorylation;GO:0006469~negative regulation of protein kinase activity;GO:0051174~regulation of phosphorus metabolic process;GO:0051338~regulation of transferase activity;GO:0009617~response to bacterium;GO:0032496~response to lipopolysaccharide;GO:0033673~negative regulation of kinase activity;GO:0051271~negative regulation of cell motion;GO:0019220~regulation of phosphate metabolic process;GO:0040013~negative regulation of locomotion;GO:0030336~negative regulation of cell migration;GO:0040012~regulation of locomotion;GO:0008285~negative regulation of cell proliferation;GO:0002237~response to molecule of bacterial origin;GO:0048660~regulation of smooth muscle cell proliferation;GO:0042127~regulation of cell proliferation;GO:0043549~regulation of kinase activity;GO:0009968~negative regulation of signal transduction	NA	NA	NA	NA
HOXB6	GO:0001501~skeletal system development;GO:0048568~embryonic organ development;GO:0042592~homeostatic process;GO:0048705~skeletal system morphogenesis	NA	GO:0003700~transcription factor activity;GO:0043565~sequence-specific DNA binding	NA	NA
CD55	GO:0002443~leukocyte mediated immunity;GO:0002252~immune effector process;GO:0006955~immune response;GO:0009611~response to wounding;GO:0006959~humoral immune response;GO:0002250~adaptive immune response;GO:0006952~defense response;GO:0006873~cellular ion homeostasis;GO:0002526~acute inflammatory response;GO:0055074~calcium ion homeostasis;GO:0006875~cellular metal ion homeostasis;GO:0006954~inflammatory response;GO:0006874~cellular calcium ion homeostasis;GO:0030003~cellular cation homeostasis;GO:0050801~ion homeostasis;GO:0055080~cation homeostasis;GO:0019725~cellular homeostasis;GO:0007204~elevation of cytosolic calcium ion concentration;GO:0055082~cellular chemical homeostasis;GO:0055065~metal ion homeostasis;GO:0055066~di-, tri-valent inorganic cation homeostasis;GO:0030005~cellular di-, tri-valent inorganic cation homeostasis;GO:0048878~chemical homeostasis;GO:0042592~homeostatic process;GO:0045087~innate immune response;GO:0002460~adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains;GO:0002684~positive regulation of immune system process	GO:0005886~plasma membrane;GO:0031226~intrinsic to plasma membrane;GO:0005887~integral to plasma membrane;GO:0045121~membrane raft;GO:0005625~soluble fraction;GO:0044459~plasma membrane part	NA	IPR000436:Sushi/SCR/CCP;IPR016060:Complement control module	hsa04610:Complement and coagulation cascades;hsa04640:Hematopoietic cell lineage
THBD	GO:0010212~response to ionizing radiation;GO:0010033~response to organic substance;GO:0009314~response to radiation;GO:0007599~hemostasis;GO:0009628~response to abiotic stimulus;GO:0051591~response to cAMP;GO:0009611~response to wounding;GO:0050878~regulation of body fluid levels;GO:0042060~wound healing;GO:0007565~female pregnancy;GO:0050817~coagulation;GO:0002237~response to molecule of bacterial origin;GO:0009617~response to bacterium;GO:0032496~response to lipopolysaccharide;GO:0007596~blood coagulation	GO:0005886~plasma membrane;GO:0031226~intrinsic to plasma membrane;GO:0005615~extracellular space;GO:0005887~integral to plasma membrane;GO:0005576~extracellular region;GO:0044421~extracellular region part;GO:0044459~plasma membrane part	GO:0005509~calcium ion binding	IPR006210:EGF-like;IPR016186:C-type lectin-like;IPR001881:EGF-like calcium-binding;IPR000742:EGF-like, type 3;IPR013032:EGF-like region, conserved site;IPR018097:EGF-like calcium-binding, conserved site;IPR006209:EGF;IPR001304:C-type lectin;IPR013091:EGF calcium-binding	hsa04610:Complement and coagulation cascades
ARC	NA	GO:0005886~plasma membrane;GO:0031982~vesicle;GO:0030141~secretory granule;GO:0031410~cytoplasmic vesicle;GO:0031988~membrane-bounded vesicle;GO:0016023~cytoplasmic membrane-bounded vesicle;GO:0044459~plasma membrane part	NA	NA	NA
AOX1	GO:0006952~defense response;GO:0009611~response to wounding;GO:0006954~inflammatory response	NA	NA	NA	hsa00760:Nicotinate and nicotinamide metabolism
MAT2A	GO:0010033~response to organic substance;GO:0048511~rhythmic process;GO:0009725~response to hormone stimulus;GO:0009314~response to radiation;GO:0009628~response to abiotic stimulus;GO:0046394~carboxylic acid biosynthetic process;GO:0051591~response to cAMP;GO:0016053~organic acid biosynthetic process;GO:0042493~response to drug;GO:0009719~response to endogenous stimulus	NA	NA	NA	NA
PDLIM3	GO:0030036~actin cytoskeleton organization;GO:0030029~actin filament-based process;GO:0007010~cytoskeleton organization;GO:0007015~actin filament organization	GO:0005730~nucleolus;GO:0030016~myofibril	NA	NA	NA
SRPX2	NA	GO:0005576~extracellular region	NA	IPR000436:Sushi/SCR/CCP;IPR016060:Complement control module	NA
MYC	GO:0045944~positive regulation of transcription from RNA polymerase II promoter;GO:0009314~response to radiation;GO:0042981~regulation of apoptosis;GO:0030262~apoptotic nuclear changes;GO:0006873~cellular ion homeostasis;GO:0043065~positive regulation of apoptosis;GO:0043067~regulation of programmed cell death;GO:0008284~positive regulation of cell proliferation;GO:0030003~cellular cation homeostasis;GO:0050801~ion homeostasis;GO:0051726~regulation of cell cycle;GO:0012501~programmed cell death;GO:0055080~cation homeostasis;GO:0019725~cellular homeostasis;GO:0048568~embryonic organ development;GO:0008629~induction of apoptosis by intracellular signals;GO:0008283~cell proliferation;GO:0055066~di-, tri-valent inorganic cation homeostasis;GO:0043066~negative regulation of apoptosis;GO:0030005~cellular di-, tri-valent inorganic cation homeostasis;GO:0048705~skeletal system morphogenesis;GO:0006879~cellular iron ion homeostasis;GO:0001501~skeletal system development;GO:0008219~cell death;GO:0042592~homeostatic process;GO:0016265~death;GO:0060548~negative regulation of cell death;GO:0043069~negative regulation of programmed cell death;GO:0010033~response to organic substance;GO:0006915~apoptosis;GO:0055072~iron ion homeostasis;GO:0043085~positive regulation of catalytic activity;GO:0010942~positive regulation of cell death;GO:0055082~cellular chemical homeostasis;GO:0009628~response to abiotic stimulus;GO:0048878~chemical homeostasis;GO:0043068~positive regulation of programmed cell death;GO:0010941~regulation of cell death;GO:0044093~positive regulation of molecular function;GO:0042127~regulation of cell proliferation	NA	GO:0003700~transcription factor activity;GO:0043565~sequence-specific DNA binding	NA	hsa05220:Chronic myeloid leukemia;hsa04012:ErbB signaling pathway;hsa04010:MAPK signaling pathway
RCAN1	GO:0008015~blood circulation;GO:0010033~response to organic substance;GO:0009725~response to hormone stimulus;GO:0043627~response to estrogen stimulus;GO:0009628~response to abiotic stimulus;GO:0045596~negative regulation of cell differentiation;GO:0048545~response to steroid hormone stimulus;GO:0019220~regulation of phosphate metabolic process;GO:0007517~muscle organ development;GO:0051174~regulation of phosphorus metabolic process;GO:0003013~circulatory system process;GO:0009719~response to endogenous stimulus	NA	GO:0003700~transcription factor activity	NA	NA
JUND	GO:0001501~skeletal system development;GO:0045669~positive regulation of osteoblast differentiation;GO:0045597~positive regulation of cell differentiation;GO:0051094~positive regulation of developmental process	NA	GO:0046983~protein dimerization activity;GO:0003700~transcription factor activity;GO:0043565~sequence-specific DNA binding	IPR004827:Basic-leucine zipper (bZIP) transcription factor;IPR011616:bZIP transcription factor, bZIP-1	hsa04010:MAPK signaling pathway
SDS	GO:0016051~carbohydrate biosynthetic process;GO:0046394~carboxylic acid biosynthetic process;GO:0034637~cellular carbohydrate biosynthetic process;GO:0016053~organic acid biosynthetic process	NA	GO:0046983~protein dimerization activity;GO:0042803~protein homodimerization activity	NA	NA
PIM1	GO:0045859~regulation of protein kinase activity;GO:0051329~interphase of mitotic cell cycle;GO:0022403~cell cycle phase;GO:0000082~G1/S transition of mitotic cell cycle;GO:0042981~regulation of apoptosis;GO:0042325~regulation of phosphorylation;GO:0000079~regulation of cyclin-dependent protein kinase activity;GO:0051347~positive regulation of transferase activity;GO:0051174~regulation of phosphorus metabolic process;GO:0045860~positive regulation of protein kinase activity;GO:0051338~regulation of transferase activity;GO:0043085~positive regulation of catalytic activity;GO:0043067~regulation of programmed cell death;GO:0051325~interphase;GO:0051726~regulation of cell cycle;GO:0008283~cell proliferation;GO:0045787~positive regulation of cell cycle;GO:0043066~negative regulation of apoptosis;GO:0019220~regulation of phosphate metabolic process;GO:0045737~positive regulation of cyclin-dependent protein kinase activity;GO:0010941~regulation of cell death;GO:0044093~positive regulation of molecular function;GO:0043549~regulation of kinase activity;GO:0033674~positive regulation of kinase activity;GO:0060548~negative regulation of cell death;GO:0043069~negative regulation of programmed cell death	GO:0005886~plasma membrane	NA	NA	NA
ADAMTS1	GO:0048511~rhythmic process;GO:0008285~negative regulation of cell proliferation;GO:0042127~regulation of cell proliferation	GO:0031982~vesicle;GO:0031012~extracellular matrix;GO:0031410~cytoplasmic vesicle;GO:0005578~proteinaceous extracellular matrix;GO:0005576~extracellular region;GO:0044421~extracellular region part	GO:0030246~carbohydrate binding;GO:0005539~glycosaminoglycan binding;GO:0008201~heparin binding;GO:0030247~polysaccharide binding;GO:0001871~pattern binding	IPR010294:ADAM-TS Spacer 1;IPR006025:Peptidase M, neutral zinc metallopeptidases, zinc-binding site;IPR013273:Peptidase M12B, ADAM-TS;IPR000884:Thrombospondin, type 1 repeat	NA
NEDD9	GO:0030036~actin cytoskeleton organization;GO:0030029~actin filament-based process;GO:0007010~cytoskeleton organization;GO:0040008~regulation of growth;GO:0007155~cell adhesion;GO:0022403~cell cycle phase;GO:0007015~actin filament organization;GO:0022610~biological adhesion	GO:0005886~plasma membrane;GO:0016323~basolateral plasma membrane;GO:0044459~plasma membrane part	NA	NA	NA
PANX1	GO:0010033~response to organic substance;GO:0001817~regulation of cytokine production;GO:0051240~positive regulation of multicellular organismal process;GO:0001819~positive regulation of cytokine production	GO:0005886~plasma membrane;GO:0044459~plasma membrane part	GO:0046983~protein dimerization activity	NA	NA
IER3	GO:0012501~programmed cell death;GO:0043066~negative regulation of apoptosis;GO:0042981~regulation of apoptosis;GO:0010941~regulation of cell death;GO:0008219~cell death;GO:0006915~apoptosis;GO:0016265~death;GO:0043067~regulation of programmed cell death;GO:0060548~negative regulation of cell death;GO:0043069~negative regulation of programmed cell death	NA	NA	NA	NA
SDC4	GO:0045859~regulation of protein kinase activity;GO:0042325~regulation of phosphorylation;GO:0019220~regulation of phosphate metabolic process;GO:0051347~positive regulation of transferase activity;GO:0051174~regulation of phosphorus metabolic process;GO:0051338~regulation of transferase activity;GO:0045860~positive regulation of protein kinase activity;GO:0044093~positive regulation of molecular function;GO:0043085~positive regulation of catalytic activity;GO:0043549~regulation of kinase activity;GO:0033674~positive regulation of kinase activity	GO:0005887~integral to plasma membrane;GO:0045121~membrane raft;GO:0030016~myofibril;GO:0016323~basolateral plasma membrane;GO:0044459~plasma membrane part;GO:0031226~intrinsic to plasma membrane;GO:0005886~plasma membrane;GO:0009986~cell surface	NA	NA	hsa04512:ECM-receptor interaction
RSAD2	GO:0006952~defense response;GO:0002252~immune effector process;GO:0006955~immune response	GO:0005886~plasma membrane;GO:0044459~plasma membrane part	NA	NA	NA
GPR4	NA	GO:0005886~plasma membrane;GO:0031226~intrinsic to plasma membrane;GO:0005887~integral to plasma membrane;GO:0044459~plasma membrane part	NA	NA	NA
ANPEP	GO:0001944~vasculature development;GO:0001525~angiogenesis;GO:0048514~blood vessel morphogenesis;GO:0001568~blood vessel development	GO:0031982~vesicle;GO:0005887~integral to plasma membrane;GO:0031988~membrane-bounded vesicle;GO:0044459~plasma membrane part;GO:0031983~vesicle lumen;GO:0031226~intrinsic to plasma membrane;GO:0005886~plasma membrane;GO:0005625~soluble fraction	GO:0042277~peptide binding	IPR006025:Peptidase M, neutral zinc metallopeptidases, zinc-binding site	hsa04640:Hematopoietic cell lineage
IL1R2	GO:0006955~immune response	NA	GO:0019955~cytokine binding;GO:0019966~interleukin-1 binding;GO:0004908~interleukin-1 receptor activity;GO:0019838~growth factor binding	IPR015621:Interleukin-1 receptor;IPR004074:Interleukin-1 receptor, type I and type II;IPR013783:Immunoglobulin-like fold;IPR003599:Immunoglobulin subtype	hsa04060:Cytokine-cytokine receptor interaction;hsa04010:MAPK signaling pathway;hsa04640:Hematopoietic cell lineage
WDR43	NA	GO:0005730~nucleolus	NA	NA	NA
CCL21	GO:0006952~defense response;GO:0007626~locomotory behavior;GO:0006955~immune response;GO:0009611~response to wounding;GO:0042330~taxis;GO:0006935~chemotaxis;GO:0006954~inflammatory response	GO:0005615~extracellular space;GO:0005576~extracellular region;GO:0044421~extracellular region part	NA	NA	hsa04060:Cytokine-cytokine receptor interaction
LILRA5	GO:0006955~immune response	GO:0005576~extracellular region	NA	NA	NA
EVA1C	NA	NA	GO:0030246~carbohydrate binding	NA	NA
FGL2	NA	GO:0005615~extracellular space;GO:0005576~extracellular region;GO:0044421~extracellular region part	NA	NA	NA
CAPG	GO:0032535~regulation of cellular component size;GO:0043254~regulation of protein complex assembly;GO:0032271~regulation of protein polymerization	GO:0031982~vesicle;GO:0031410~cytoplasmic vesicle;GO:0031988~membrane-bounded vesicle;GO:0016023~cytoplasmic membrane-bounded vesicle	NA	NA	NA
HAS1	GO:0016051~carbohydrate biosynthetic process;GO:0007155~cell adhesion;GO:0000271~polysaccharide biosynthetic process;GO:0022610~biological adhesion	GO:0005886~plasma membrane;GO:0031226~intrinsic to plasma membrane;GO:0005887~integral to plasma membrane;GO:0044459~plasma membrane part	NA	IPR001173:Glycosyl transferase, family 2	NA
WEE1	GO:0022403~cell cycle phase	NA	NA	NA	NA
PTGFRN	NA	NA	NA	IPR013783:Immunoglobulin-like fold;IPR003599:Immunoglobulin subtype	NA
TPPP	GO:0007010~cytoskeleton organization;GO:0043254~regulation of protein complex assembly;GO:0032271~regulation of protein polymerization;GO:0051258~protein polymerization;GO:0032273~positive regulation of protein polymerization	GO:0005625~soluble fraction	NA	NA	NA
AQP3	GO:0007584~response to nutrient;GO:0033273~response to vitamin;GO:0031667~response to nutrient levels;GO:0033189~response to vitamin A;GO:0009991~response to extracellular stimulus;GO:0002684~positive regulation of immune system process	GO:0005886~plasma membrane;GO:0016323~basolateral plasma membrane;GO:0044459~plasma membrane part	NA	NA	NA
NAMPT	GO:0008284~positive regulation of cell proliferation;GO:0042127~regulation of cell proliferation	NA	GO:0016763~transferase activity, transferring pentosyl groups	NA	hsa00760:Nicotinate and nicotinamide metabolism
CKB	GO:0050801~ion homeostasis;GO:0019725~cellular homeostasis;GO:0042592~homeostatic process;GO:0055082~cellular chemical homeostasis;GO:0006873~cellular ion homeostasis;GO:0048878~chemical homeostasis	NA	NA	NA	NA
MAFF	NA	NA	GO:0003700~transcription factor activity;GO:0043565~sequence-specific DNA binding	IPR004827:Basic-leucine zipper (bZIP) transcription factor	NA
IL1RL1	GO:0006952~defense response;GO:0045087~innate immune response;GO:0006955~immune response;GO:0009968~negative regulation of signal transduction	GO:0005886~plasma membrane;GO:0009986~cell surface;GO:0005576~extracellular region;GO:0016323~basolateral plasma membrane;GO:0044459~plasma membrane part	GO:0019955~cytokine binding;GO:0019966~interleukin-1 binding;GO:0004908~interleukin-1 receptor activity;GO:0019838~growth factor binding	IPR004075:Interleukin-1 receptor, type I/Toll precursor;IPR015621:Interleukin-1 receptor;IPR004074:Interleukin-1 receptor, type I and type II;IPR013783:Immunoglobulin-like fold;IPR003599:Immunoglobulin subtype	NA
RGS3	GO:0045859~regulation of protein kinase activity;GO:0051348~negative regulation of transferase activity;GO:0042325~regulation of phosphorylation;GO:0019220~regulation of phosphate metabolic process;GO:0006469~negative regulation of protein kinase activity;GO:0051174~regulation of phosphorus metabolic process;GO:0051338~regulation of transferase activity;GO:0043549~regulation of kinase activity;GO:0033673~negative regulation of kinase activity;GO:0009968~negative regulation of signal transduction	GO:0005886~plasma membrane	NA	NA	NA
SLC2A4	GO:0042592~homeostatic process;GO:0048878~chemical homeostasis	GO:0031982~vesicle;GO:0030141~secretory granule;GO:0005887~integral to plasma membrane;GO:0031410~cytoplasmic vesicle;GO:0031988~membrane-bounded vesicle;GO:0044459~plasma membrane part;GO:0031226~intrinsic to plasma membrane;GO:0005886~plasma membrane;GO:0009986~cell surface;GO:0005625~soluble fraction;GO:0016023~cytoplasmic membrane-bounded vesicle	NA	NA	NA
RYR3	GO:0006874~cellular calcium ion homeostasis;GO:0050801~ion homeostasis;GO:0030003~cellular cation homeostasis;GO:0019725~cellular homeostasis;GO:0055080~cation homeostasis;GO:0055082~cellular chemical homeostasis;GO:0055065~metal ion homeostasis;GO:0055066~di-, tri-valent inorganic cation homeostasis;GO:0048878~chemical homeostasis;GO:0030005~cellular di-, tri-valent inorganic cation homeostasis;GO:0042592~homeostatic process;GO:0006873~cellular ion homeostasis;GO:0055074~calcium ion homeostasis;GO:0006875~cellular metal ion homeostasis	NA	GO:0005509~calcium ion binding	NA	NA
CRIP1	GO:0008283~cell proliferation	NA	NA	NA	NA
CRY1	GO:0048511~rhythmic process	NA	NA	NA	NA
HSPB8	GO:0008219~cell death;GO:0009628~response to abiotic stimulus;GO:0016265~death	NA	NA	NA	NA
LBP	GO:0010033~response to organic substance;GO:0002675~positive regulation of acute inflammatory response;GO:0002263~cell activation during immune response;GO:0050727~regulation of inflammatory response;GO:0002252~immune effector process;GO:0006955~immune response;GO:0009611~response to wounding;GO:0006953~acute-phase response;GO:0050865~regulation of cell activation;GO:0001817~regulation of cytokine production;GO:0006952~defense response;GO:0002526~acute inflammatory response;GO:0050867~positive regulation of cell activation;GO:0009617~response to bacterium;GO:0032496~response to lipopolysaccharide;GO:0006954~inflammatory response;GO:0032103~positive regulation of response to external stimulus;GO:0002366~leukocyte activation during immune response;GO:0050829~defense response to Gram-negative bacterium;GO:0051240~positive regulation of multicellular organismal process;GO:0032101~regulation of response to external stimulus;GO:0002237~response to molecule of bacterial origin;GO:0045087~innate immune response;GO:0001819~positive regulation of cytokine production;GO:0002684~positive regulation of immune system process	GO:0005615~extracellular space;GO:0005576~extracellular region;GO:0044421~extracellular region part	NA	NA	NA
PTPN1	GO:0010033~response to organic substance;GO:0009725~response to hormone stimulus;GO:0009719~response to endogenous stimulus;GO:0009968~negative regulation of signal transduction	GO:0005886~plasma membrane;GO:0031982~vesicle;GO:0031410~cytoplasmic vesicle;GO:0044459~plasma membrane part	GO:0032403~protein complex binding	NA	NA
RHOU	GO:0030036~actin cytoskeleton organization;GO:0030029~actin filament-based process;GO:0008360~regulation of cell shape;GO:0007010~cytoskeleton organization;GO:0051329~interphase of mitotic cell cycle;GO:0022403~cell cycle phase;GO:0022604~regulation of cell morphogenesis;GO:0000082~G1/S transition of mitotic cell cycle;GO:0051325~interphase	GO:0005886~plasma membrane;GO:0016323~basolateral plasma membrane;GO:0044459~plasma membrane part	NA	NA	NA
TGFBI	GO:0007155~cell adhesion;GO:0008283~cell proliferation;GO:0043062~extracellular structure organization;GO:0030198~extracellular matrix organization;GO:0022610~biological adhesion	GO:0005615~extracellular space;GO:0031012~extracellular matrix;GO:0005578~proteinaceous extracellular matrix;GO:0005576~extracellular region;GO:0044421~extracellular region part	GO:0032403~protein complex binding;GO:0005178~integrin binding	NA	NA
CCR1	GO:0007626~locomotory behavior;GO:0006955~immune response;GO:0009611~response to wounding;GO:0042330~taxis;GO:0006935~chemotaxis;GO:0006952~defense response;GO:0006873~cellular ion homeostasis;GO:0055074~calcium ion homeostasis;GO:0006875~cellular metal ion homeostasis;GO:0006954~inflammatory response;GO:0006874~cellular calcium ion homeostasis;GO:0030003~cellular cation homeostasis;GO:0050801~ion homeostasis;GO:0019725~cellular homeostasis;GO:0007155~cell adhesion;GO:0055080~cation homeostasis;GO:0007204~elevation of cytosolic calcium ion concentration;GO:0055082~cellular chemical homeostasis;GO:0055065~metal ion homeostasis;GO:0055066~di-, tri-valent inorganic cation homeostasis;GO:0030005~cellular di-, tri-valent inorganic cation homeostasis;GO:0048878~chemical homeostasis;GO:0042592~homeostatic process;GO:0022610~biological adhesion	GO:0005886~plasma membrane;GO:0031226~intrinsic to plasma membrane;GO:0005887~integral to plasma membrane;GO:0044459~plasma membrane part	GO:0019955~cytokine binding;GO:0008528~peptide receptor activity, G-protein coupled;GO:0042277~peptide binding;GO:0001653~peptide receptor activity	NA	hsa04060:Cytokine-cytokine receptor interaction
PLA2G2A	GO:0050727~regulation of inflammatory response;GO:0048864~stem cell development;GO:0045596~negative regulation of cell differentiation;GO:0032103~positive regulation of response to external stimulus;GO:0019827~stem cell maintenance;GO:0006952~defense response;GO:0032101~regulation of response to external stimulus;GO:0008285~negative regulation of cell proliferation;GO:0042127~regulation of cell proliferation;GO:0045597~positive regulation of cell differentiation;GO:0051094~positive regulation of developmental process;GO:0009617~response to bacterium	GO:0031982~vesicle;GO:0030141~secretory granule;GO:0031410~cytoplasmic vesicle;GO:0031988~membrane-bounded vesicle;GO:0005576~extracellular region;GO:0005615~extracellular space;GO:0044421~extracellular region part;GO:0016023~cytoplasmic membrane-bounded vesicle	GO:0005509~calcium ion binding	NA	hsa04010:MAPK signaling pathway
CBLN1	NA	GO:0005886~plasma membrane;GO:0005576~extracellular region;GO:0044459~plasma membrane part	GO:0046983~protein dimerization activity;GO:0042803~protein homodimerization activity	NA	NA
SOCS3	GO:0009314~response to radiation;GO:0043627~response to estrogen stimulus;GO:0042981~regulation of apoptosis;GO:0001666~response to hypoxia;GO:0034097~response to cytokine stimulus;GO:0051174~regulation of phosphorus metabolic process;GO:0014070~response to organic cyclic substance;GO:0043067~regulation of programmed cell death;GO:0045597~positive regulation of cell differentiation;GO:0043066~negative regulation of apoptosis;GO:0031667~response to nutrient levels;GO:0009991~response to extracellular stimulus;GO:0060548~negative regulation of cell death;GO:0051094~positive regulation of developmental process;GO:0070482~response to oxygen levels;GO:0009968~negative regulation of signal transduction;GO:0043069~negative regulation of programmed cell death;GO:0010033~response to organic substance;GO:0048545~response to steroid hormone stimulus;GO:0042325~regulation of phosphorylation;GO:0032496~response to lipopolysaccharide;GO:0009617~response to bacterium;GO:0032570~response to progesterone stimulus;GO:0010212~response to ionizing radiation;GO:0009725~response to hormone stimulus;GO:0009628~response to abiotic stimulus;GO:0019220~regulation of phosphate metabolic process;GO:0031100~organ regeneration;GO:0010941~regulation of cell death;GO:0031099~regeneration;GO:0042493~response to drug;GO:0040008~regulation of growth;GO:0002237~response to molecule of bacterial origin;GO:0009719~response to endogenous stimulus	NA	NA	NA	NA
MAP3K8	NA	NA	NA	NA	hsa04010:MAPK signaling pathway
CLU	GO:0002443~leukocyte mediated immunity;GO:0002252~immune effector process;GO:0006955~immune response;GO:0009611~response to wounding;GO:0042981~regulation of apoptosis;GO:0006959~humoral immune response;GO:0002250~adaptive immune response;GO:0043254~regulation of protein complex assembly;GO:0006952~defense response;GO:0006915~apoptosis;GO:0002526~acute inflammatory response;GO:0043067~regulation of programmed cell death;GO:0045597~positive regulation of cell differentiation;GO:0006954~inflammatory response;GO:0008284~positive regulation of cell proliferation;GO:0012501~programmed cell death;GO:0043066~negative regulation of apoptosis;GO:0010941~regulation of cell death;GO:0008219~cell death;GO:0016265~death;GO:0045087~innate immune response;GO:0042127~regulation of cell proliferation;GO:0002460~adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains;GO:0051094~positive regulation of developmental process;GO:0060548~negative regulation of cell death;GO:0043069~negative regulation of programmed cell death;GO:0002684~positive regulation of immune system process	GO:0034358~plasma lipoprotein particle;GO:0031093~platelet alpha granule lumen;GO:0031982~vesicle;GO:0030141~secretory granule;GO:0031410~cytoplasmic vesicle;GO:0044433~cytoplasmic vesicle part;GO:0031988~membrane-bounded vesicle;GO:0005576~extracellular region;GO:0031091~platelet alpha granule;GO:0031983~vesicle lumen;GO:0005615~extracellular space;GO:0044421~extracellular region part;GO:0016023~cytoplasmic membrane-bounded vesicle;GO:0032994~protein-lipid complex;GO:0060205~cytoplasmic membrane-bounded vesicle lumen	NA	NA	NA
SEMA4A	NA	GO:0005886~plasma membrane	NA	NA	NA
TIPARP	GO:0060325~face morphogenesis;GO:0044236~multicellular organismal metabolic process;GO:0060323~head morphogenesis;GO:0048514~blood vessel morphogenesis;GO:0048705~skeletal system morphogenesis;GO:0007517~muscle organ development;GO:0001944~vasculature development;GO:0001501~skeletal system development;GO:0009791~post-embryonic development;GO:0060324~face development;GO:0001568~blood vessel development	NA	GO:0016763~transferase activity, transferring pentosyl groups	NA	NA
MMP19	GO:0001944~vasculature development;GO:0044236~multicellular organismal metabolic process;GO:0032963~collagen metabolic process;GO:0001525~angiogenesis;GO:0048514~blood vessel morphogenesis;GO:0001568~blood vessel development	GO:0031012~extracellular matrix;GO:0005578~proteinaceous extracellular matrix;GO:0005576~extracellular region;GO:0044421~extracellular region part	GO:0005509~calcium ion binding	IPR006025:Peptidase M, neutral zinc metallopeptidases, zinc-binding site;IPR001818:Peptidase M10A and M12B, matrixin and adamalysin	NA
PROCR	GO:0050878~regulation of body fluid levels;GO:0007599~hemostasis;GO:0042060~wound healing;GO:0050817~coagulation;GO:0006955~immune response;GO:0009611~response to wounding;GO:0007596~blood coagulation	GO:0005886~plasma membrane;GO:0031226~intrinsic to plasma membrane;GO:0005887~integral to plasma membrane;GO:0044459~plasma membrane part	NA	NA	NA
LPAR1	GO:0045859~regulation of protein kinase activity;GO:0042325~regulation of phosphorylation;GO:0051347~positive regulation of transferase activity;GO:0051174~regulation of phosphorus metabolic process;GO:0045860~positive regulation of protein kinase activity;GO:0006873~cellular ion homeostasis;GO:0051338~regulation of transferase activity;GO:0043085~positive regulation of catalytic activity;GO:0055074~calcium ion homeostasis;GO:0006875~cellular metal ion homeostasis;GO:0006874~cellular calcium ion homeostasis;GO:0030003~cellular cation homeostasis;GO:0050801~ion homeostasis;GO:0055080~cation homeostasis;GO:0019725~cellular homeostasis;GO:0007204~elevation of cytosolic calcium ion concentration;GO:0055082~cellular chemical homeostasis;GO:0055065~metal ion homeostasis;GO:0055066~di-, tri-valent inorganic cation homeostasis;GO:0030005~cellular di-, tri-valent inorganic cation homeostasis;GO:0019220~regulation of phosphate metabolic process;GO:0048878~chemical homeostasis;GO:0042592~homeostatic process;GO:0044093~positive regulation of molecular function;GO:0043549~regulation of kinase activity;GO:0033674~positive regulation of kinase activity	GO:0005886~plasma membrane;GO:0031226~intrinsic to plasma membrane;GO:0005887~integral to plasma membrane;GO:0044459~plasma membrane part	NA	NA	NA
SAMD4A	GO:0045727~positive regulation of translation	GO:0005886~plasma membrane;GO:0044459~plasma membrane part	NA	NA	NA
CENPF	GO:0051726~regulation of cell cycle;GO:0042493~response to drug;GO:0051329~interphase of mitotic cell cycle;GO:0008283~cell proliferation;GO:0022403~cell cycle phase;GO:0051325~interphase;GO:0007517~muscle organ development	NA	GO:0046983~protein dimerization activity;GO:0042803~protein homodimerization activity	NA	NA
SLC4A7	NA	GO:0005886~plasma membrane	NA	IPR011531:Bicarbonate transporter, C-terminal;IPR003020:Bicarbonate transporter, eukaryotic;IPR013769:Bicarbonate transporter, cytoplasmic	NA
PHLDA1	GO:0012501~programmed cell death;GO:0042981~regulation of apoptosis;GO:0043068~positive regulation of programmed cell death;GO:0010941~regulation of cell death;GO:0008219~cell death;GO:0006915~apoptosis;GO:0016265~death;GO:0043067~regulation of programmed cell death;GO:0043065~positive regulation of apoptosis;GO:0010942~positive regulation of cell death	GO:0031982~vesicle;GO:0031410~cytoplasmic vesicle;GO:0005730~nucleolus;GO:0044433~cytoplasmic vesicle part;GO:0031988~membrane-bounded vesicle;GO:0016023~cytoplasmic membrane-bounded vesicle	NA	NA	NA
BTNL9	NA	NA	NA	IPR013783:Immunoglobulin-like fold;IPR003599:Immunoglobulin subtype	NA
TNFRSF12A	GO:0031344~regulation of cell projection organization;GO:0022604~regulation of cell morphogenesis;GO:0006929~substrate-bound cell migration;GO:0051674~localization of cell;GO:0001944~vasculature development;GO:0045793~positive regulation of cell size;GO:0006928~cell motion;GO:0006915~apoptosis;GO:0031346~positive regulation of cell projection organization;GO:0008361~regulation of cell size;GO:0045597~positive regulation of cell differentiation;GO:0001568~blood vessel development;GO:0048870~cell motility;GO:0045773~positive regulation of axon extension;GO:0012501~programmed cell death;GO:0007155~cell adhesion;GO:0030307~positive regulation of cell growth;GO:0001525~angiogenesis;GO:0048514~blood vessel morphogenesis;GO:0032535~regulation of cellular component size;GO:0016477~cell migration;GO:0040008~regulation of growth;GO:0008219~cell death;GO:0001558~regulation of cell growth;GO:0016265~death;GO:0051094~positive regulation of developmental process;GO:0022610~biological adhesion	GO:0005886~plasma membrane;GO:0009986~cell surface	NA	NA	hsa04060:Cytokine-cytokine receptor interaction
ZFP36	GO:0050727~regulation of inflammatory response;GO:0032101~regulation of response to external stimulus;GO:0045596~negative regulation of cell differentiation	NA	NA	NA	NA
MUC1	GO:0007584~response to nutrient;GO:0033273~response to vitamin;GO:0031667~response to nutrient levels;GO:0033189~response to vitamin A;GO:0007565~female pregnancy;GO:0009991~response to extracellular stimulus	GO:0005886~plasma membrane;GO:0031226~intrinsic to plasma membrane;GO:0005887~integral to plasma membrane;GO:0005576~extracellular region;GO:0044459~plasma membrane part	NA	NA	NA
APOL4	NA	GO:0005576~extracellular region	NA	NA	NA
IGFBP6	GO:0040008~regulation of growth;GO:0008285~negative regulation of cell proliferation;GO:0001558~regulation of cell growth;GO:0042127~regulation of cell proliferation	GO:0005615~extracellular space;GO:0005576~extracellular region;GO:0044421~extracellular region part	GO:0019838~growth factor binding;GO:0005520~insulin-like growth factor binding	IPR000867:Insulin-like growth factor-binding protein, IGFBP;IPR017891:Insulin-like growth factor binding protein, N-terminal	NA
EGFEM1P	NA	NA	NA	IPR013032:EGF-like region, conserved site	NA
MFAP5	NA	GO:0031012~extracellular matrix;GO:0005578~proteinaceous extracellular matrix;GO:0005576~extracellular region;GO:0044421~extracellular region part	NA	NA	NA
CASP7	GO:0012501~programmed cell death;GO:0008219~cell death;GO:0009314~response to radiation;GO:0006915~apoptosis;GO:0009628~response to abiotic stimulus;GO:0016265~death;GO:0009411~response to UV	GO:0005625~soluble fraction	NA	NA	NA
ADGRE5	GO:0007155~cell adhesion;GO:0006928~cell motion;GO:0006952~defense response;GO:0006955~immune response;GO:0009611~response to wounding;GO:0022610~biological adhesion;GO:0006954~inflammatory response	GO:0005886~plasma membrane;GO:0031226~intrinsic to plasma membrane;GO:0005615~extracellular space;GO:0005887~integral to plasma membrane;GO:0005576~extracellular region;GO:0044421~extracellular region part;GO:0044459~plasma membrane part	GO:0005509~calcium ion binding	IPR018097:EGF-like calcium-binding, conserved site;IPR013091:EGF calcium-binding;IPR001881:EGF-like calcium-binding;IPR000742:EGF-like, type 3	NA
CTGF	GO:0007155~cell adhesion;GO:0001525~angiogenesis;GO:0048514~blood vessel morphogenesis;GO:0009611~response to wounding;GO:0048705~skeletal system morphogenesis;GO:0051674~localization of cell;GO:0001501~skeletal system development;GO:0001944~vasculature development;GO:0016477~cell migration;GO:0040008~regulation of growth;GO:0006928~cell motion;GO:0001558~regulation of cell growth;GO:0022610~biological adhesion;GO:0001568~blood vessel development;GO:0048870~cell motility	GO:0005886~plasma membrane;GO:0031012~extracellular matrix;GO:0005578~proteinaceous extracellular matrix;GO:0005576~extracellular region;GO:0044421~extracellular region part	GO:0032403~protein complex binding;GO:0030246~carbohydrate binding;GO:0005539~glycosaminoglycan binding;GO:0008201~heparin binding;GO:0030247~polysaccharide binding;GO:0005520~insulin-like growth factor binding;GO:0005178~integrin binding;GO:0001871~pattern binding;GO:0008083~growth factor activity;GO:0019838~growth factor binding	IPR000867:Insulin-like growth factor-binding protein, IGFBP;IPR017891:Insulin-like growth factor binding protein, N-terminal;IPR000884:Thrombospondin, type 1 repeat	NA
KPNA2	GO:0051329~interphase of mitotic cell cycle;GO:0022403~cell cycle phase;GO:0051325~interphase	NA	GO:0042277~peptide binding	NA	NA
SEC24D	NA	GO:0031982~vesicle;GO:0031410~cytoplasmic vesicle;GO:0044433~cytoplasmic vesicle part;GO:0031988~membrane-bounded vesicle;GO:0016023~cytoplasmic membrane-bounded vesicle	NA	NA	NA
ADAMTS9	NA	GO:0031012~extracellular matrix;GO:0005578~proteinaceous extracellular matrix;GO:0005576~extracellular region;GO:0044421~extracellular region part	NA	IPR010294:ADAM-TS Spacer 1;IPR006025:Peptidase M, neutral zinc metallopeptidases, zinc-binding site;IPR013273:Peptidase M12B, ADAM-TS;IPR001818:Peptidase M10A and M12B, matrixin and adamalysin;IPR000884:Thrombospondin, type 1 repeat	NA
RGS16	GO:0009968~negative regulation of signal transduction	GO:0045121~membrane raft	NA	NA	NA
UGCG	NA	NA	GO:0035251~UDP-glucosyltransferase activity;GO:0046527~glucosyltransferase activity	IPR001173:Glycosyl transferase, family 2	NA
PRSS1	NA	GO:0005615~extracellular space;GO:0005576~extracellular region;GO:0044421~extracellular region part	GO:0005509~calcium ion binding	NA	NA
LMNA	GO:0007517~muscle organ development	GO:0005886~plasma membrane	NA	NA	NA
ADGRD1	NA	GO:0005886~plasma membrane	NA	NA	NA
PLA1A	NA	GO:0005576~extracellular region	NA	NA	NA
PNO1	NA	GO:0005730~nucleolus	NA	NA	NA
DNASE1L3	GO:0030262~apoptotic nuclear changes;GO:0012501~programmed cell death;GO:0008219~cell death;GO:0006915~apoptosis;GO:0016265~death	NA	GO:0005509~calcium ion binding	NA	NA
GYS2	GO:0010033~response to organic substance;GO:0016051~carbohydrate biosynthetic process;GO:0000271~polysaccharide biosynthetic process;GO:0034637~cellular carbohydrate biosynthetic process	GO:0005625~soluble fraction	GO:0046983~protein dimerization activity;GO:0042803~protein homodimerization activity;GO:0035251~UDP-glucosyltransferase activity;GO:0046527~glucosyltransferase activity	NA	NA
HSD3B7	GO:0045727~positive regulation of translation;GO:0048864~stem cell development;GO:0045596~negative regulation of cell differentiation;GO:0046394~carboxylic acid biosynthetic process;GO:0019827~stem cell maintenance;GO:0022403~cell cycle phase;GO:0016053~organic acid biosynthetic process	NA	NA	NA	NA
CD248	NA	GO:0031012~extracellular matrix;GO:0005578~proteinaceous extracellular matrix;GO:0005576~extracellular region;GO:0044421~extracellular region part	GO:0030246~carbohydrate binding;GO:0005509~calcium ion binding	IPR018378:C-type lectin, conserved site;IPR006210:EGF-like;IPR016186:C-type lectin-like;IPR001881:EGF-like calcium-binding;IPR013032:EGF-like region, conserved site;IPR018097:EGF-like calcium-binding, conserved site;IPR006209:EGF;IPR001304:C-type lectin;IPR013091:EGF calcium-binding	NA
STX11	NA	GO:0005886~plasma membrane	NA	NA	NA
CDC42EP2	GO:0030036~actin cytoskeleton organization;GO:0030029~actin filament-based process;GO:0008360~regulation of cell shape;GO:0007010~cytoskeleton organization;GO:0031344~regulation of cell projection organization;GO:0022604~regulation of cell morphogenesis;GO:0032535~regulation of cellular component size;GO:0043254~regulation of protein complex assembly;GO:0031346~positive regulation of cell projection organization;GO:0032271~regulation of protein polymerization;GO:0007015~actin filament organization;GO:0032273~positive regulation of protein polymerization	GO:0005886~plasma membrane	NA	NA	NA
SERTAD1	GO:0045859~regulation of protein kinase activity;GO:0008284~positive regulation of cell proliferation;GO:0051726~regulation of cell cycle;GO:0042325~regulation of phosphorylation;GO:0019220~regulation of phosphate metabolic process;GO:0000079~regulation of cyclin-dependent protein kinase activity;GO:0032535~regulation of cellular component size;GO:0040008~regulation of growth;GO:0051174~regulation of phosphorus metabolic process;GO:0051338~regulation of transferase activity;GO:0008361~regulation of cell size;GO:0001558~regulation of cell growth;GO:0042127~regulation of cell proliferation;GO:0043549~regulation of kinase activity	NA	NA	NA	NA
PDGFB	GO:0051270~regulation of cell motion;GO:0030029~actin filament-based process;GO:0043627~response to estrogen stimulus;GO:0007626~locomotory behavior;GO:0040017~positive regulation of locomotion;GO:0009611~response to wounding;GO:0060326~cell chemotaxis;GO:0030334~regulation of cell migration;GO:0051272~positive regulation of cell motion;GO:0006929~substrate-bound cell migration;GO:0051347~positive regulation of transferase activity;GO:0001666~response to hypoxia;GO:0050865~regulation of cell activation;GO:0030595~leukocyte chemotaxis;GO:0030335~positive regulation of cell migration;GO:0051174~regulation of phosphorus metabolic process;GO:0051338~regulation of transferase activity;GO:0008361~regulation of cell size;GO:0008284~positive regulation of cell proliferation;GO:0008283~cell proliferation;GO:0040013~negative regulation of locomotion;GO:0030336~negative regulation of cell migration;GO:0032535~regulation of cellular component size;GO:0070482~response to oxygen levels;GO:0010033~response to organic substance;GO:0045859~regulation of protein kinase activity;GO:0007010~cytoskeleton organization;GO:0050900~leukocyte migration;GO:0048545~response to steroid hormone stimulus;GO:0042330~taxis;GO:0042325~regulation of phosphorylation;GO:0051674~localization of cell;GO:0006935~chemotaxis;GO:0006928~cell motion;GO:0045860~positive regulation of protein kinase activity;GO:0043085~positive regulation of catalytic activity;GO:0048870~cell motility;GO:0051271~negative regulation of cell motion;GO:0030036~actin cytoskeleton organization;GO:0009725~response to hormone stimulus;GO:0048146~positive regulation of fibroblast proliferation;GO:0032103~positive regulation of response to external stimulus;GO:0019220~regulation of phosphate metabolic process;GO:0040012~regulation of locomotion;GO:0016477~cell migration;GO:0002548~monocyte chemotaxis;GO:0042060~wound healing;GO:0032101~regulation of response to external stimulus;GO:0048660~regulation of smooth muscle cell proliferation;GO:0044093~positive regulation of molecular function;GO:0009719~response to endogenous stimulus;GO:0042127~regulation of cell proliferation;GO:0043549~regulation of kinase activity;GO:0033674~positive regulation of kinase activity	GO:0031982~vesicle;GO:0030141~secretory granule;GO:0031410~cytoplasmic vesicle;GO:0044433~cytoplasmic vesicle part;GO:0031988~membrane-bounded vesicle;GO:0005576~extracellular region;GO:0031983~vesicle lumen;GO:0009986~cell surface;GO:0016023~cytoplasmic membrane-bounded vesicle;GO:0060205~cytoplasmic membrane-bounded vesicle lumen	GO:0005518~collagen binding;GO:0046983~protein dimerization activity;GO:0008083~growth factor activity;GO:0042803~protein homodimerization activity;GO:0019838~growth factor binding	NA	hsa04060:Cytokine-cytokine receptor interaction;hsa04010:MAPK signaling pathway
BATF	NA	NA	GO:0046983~protein dimerization activity;GO:0003700~transcription factor activity;GO:0043565~sequence-specific DNA binding	IPR004827:Basic-leucine zipper (bZIP) transcription factor;IPR011616:bZIP transcription factor, bZIP-1;IPR000837:Fos transforming protein	NA
CREB3L2	GO:0010033~response to organic substance	NA	GO:0046983~protein dimerization activity;GO:0003700~transcription factor activity;GO:0043565~sequence-specific DNA binding	IPR004827:Basic-leucine zipper (bZIP) transcription factor;IPR011616:bZIP transcription factor, bZIP-1	NA
PCK1	GO:0010033~response to organic substance;GO:0009725~response to hormone stimulus;GO:0016051~carbohydrate biosynthetic process;GO:0042592~homeostatic process;GO:0009719~response to endogenous stimulus;GO:0034637~cellular carbohydrate biosynthetic process;GO:0048878~chemical homeostasis	GO:0005730~nucleolus;GO:0005625~soluble fraction	NA	NA	NA
B4GALT1	GO:0051270~regulation of cell motion;GO:0009611~response to wounding;GO:0042981~regulation of apoptosis;GO:0001944~vasculature development;GO:0016051~carbohydrate biosynthetic process;GO:0043065~positive regulation of apoptosis;GO:0043067~regulation of programmed cell death;GO:0001568~blood vessel development;GO:0008284~positive regulation of cell proliferation;GO:0007155~cell adhesion;GO:0001525~angiogenesis;GO:0030198~extracellular matrix organization;GO:0048514~blood vessel morphogenesis;GO:0051240~positive regulation of multicellular organismal process;GO:0008285~negative regulation of cell proliferation;GO:0051094~positive regulation of developmental process;GO:0050900~leukocyte migration;GO:0051674~localization of cell;GO:0006952~defense response;GO:0006928~cell motion;GO:0002526~acute inflammatory response;GO:0010942~positive regulation of cell death;GO:0006954~inflammatory response;GO:0048870~cell motility;GO:0043068~positive regulation of programmed cell death;GO:0016477~cell migration;GO:0010941~regulation of cell death;GO:0042060~wound healing;GO:0042127~regulation of cell proliferation;GO:0043062~extracellular structure organization;GO:0034637~cellular carbohydrate biosynthetic process;GO:0022610~biological adhesion	GO:0005886~plasma membrane;GO:0009986~cell surface;GO:0005576~extracellular region;GO:0016323~basolateral plasma membrane;GO:0044459~plasma membrane part	GO:0046983~protein dimerization activity;GO:0042803~protein homodimerization activity	NA	NA
FPR1	GO:0045859~regulation of protein kinase activity;GO:0007626~locomotory behavior;GO:0042325~regulation of phosphorylation;GO:0042330~taxis;GO:0019220~regulation of phosphate metabolic process;GO:0006935~chemotaxis;GO:0051347~positive regulation of transferase activity;GO:0006928~cell motion;GO:0051174~regulation of phosphorus metabolic process;GO:0045860~positive regulation of protein kinase activity;GO:0051338~regulation of transferase activity;GO:0044093~positive regulation of molecular function;GO:0043085~positive regulation of catalytic activity;GO:0043549~regulation of kinase activity;GO:0033674~positive regulation of kinase activity	GO:0005886~plasma membrane	GO:0008528~peptide receptor activity, G-protein coupled;GO:0042277~peptide binding;GO:0001653~peptide receptor activity	NA	NA
CRHBP	GO:0007565~female pregnancy	GO:0005615~extracellular space;GO:0005625~soluble fraction;GO:0005576~extracellular region;GO:0044421~extracellular region part	GO:0042277~peptide binding	NA	NA
ALOX5AP	GO:0006690~icosanoid metabolic process;GO:0046394~carboxylic acid biosynthetic process;GO:0016053~organic acid biosynthetic process	NA	NA	NA	NA
ATP1A1	GO:0008015~blood circulation;GO:0042493~response to drug;GO:0003013~circulatory system process;GO:0051240~positive regulation of multicellular organismal process	GO:0031982~vesicle;GO:0005887~integral to plasma membrane;GO:0031410~cytoplasmic vesicle;GO:0031988~membrane-bounded vesicle;GO:0016323~basolateral plasma membrane;GO:0044459~plasma membrane part;GO:0031226~intrinsic to plasma membrane;GO:0005886~plasma membrane;GO:0016023~cytoplasmic membrane-bounded vesicle	NA	NA	NA
ACKR1	GO:0006952~defense response;GO:0009611~response to wounding;GO:0006954~inflammatory response	GO:0005886~plasma membrane	GO:0019955~cytokine binding;GO:0008528~peptide receptor activity, G-protein coupled;GO:0042277~peptide binding;GO:0001653~peptide receptor activity	NA	NA
FJX1	NA	GO:0005615~extracellular space;GO:0005576~extracellular region;GO:0044421~extracellular region part	NA	NA	NA
GFPT2	GO:0016051~carbohydrate biosynthetic process	NA	GO:0030246~carbohydrate binding	NA	NA
IL1R1	GO:0010033~response to organic substance;GO:0034097~response to cytokine stimulus;GO:0006952~defense response;GO:0045087~innate immune response;GO:0006955~immune response	GO:0005886~plasma membrane;GO:0031226~intrinsic to plasma membrane;GO:0005887~integral to plasma membrane;GO:0044459~plasma membrane part	GO:0019955~cytokine binding;GO:0019966~interleukin-1 binding;GO:0004908~interleukin-1 receptor activity;GO:0019838~growth factor binding	IPR004075:Interleukin-1 receptor, type I/Toll precursor;IPR015621:Interleukin-1 receptor;IPR004074:Interleukin-1 receptor, type I and type II;IPR013783:Immunoglobulin-like fold;IPR003599:Immunoglobulin subtype	hsa04060:Cytokine-cytokine receptor interaction;hsa04010:MAPK signaling pathway;hsa04640:Hematopoietic cell lineage
C5AR1	GO:0045859~regulation of protein kinase activity;GO:0007626~locomotory behavior;GO:0006955~immune response;GO:0042325~regulation of phosphorylation;GO:0042330~taxis;GO:0006935~chemotaxis;GO:0051347~positive regulation of transferase activity;GO:0006952~defense response;GO:0051174~regulation of phosphorus metabolic process;GO:0045860~positive regulation of protein kinase activity;GO:0006873~cellular ion homeostasis;GO:0051338~regulation of transferase activity;GO:0043085~positive regulation of catalytic activity;GO:0055074~calcium ion homeostasis;GO:0006875~cellular metal ion homeostasis;GO:0006874~cellular calcium ion homeostasis;GO:0050801~ion homeostasis;GO:0030003~cellular cation homeostasis;GO:0019725~cellular homeostasis;GO:0055080~cation homeostasis;GO:0007204~elevation of cytosolic calcium ion concentration;GO:0055082~cellular chemical homeostasis;GO:0055065~metal ion homeostasis;GO:0055066~di-, tri-valent inorganic cation homeostasis;GO:0030005~cellular di-, tri-valent inorganic cation homeostasis;GO:0019220~regulation of phosphate metabolic process;GO:0048878~chemical homeostasis;GO:0042592~homeostatic process;GO:0044093~positive regulation of molecular function;GO:0043549~regulation of kinase activity;GO:0033674~positive regulation of kinase activity	GO:0005886~plasma membrane;GO:0031226~intrinsic to plasma membrane;GO:0005887~integral to plasma membrane;GO:0044459~plasma membrane part	GO:0008528~peptide receptor activity, G-protein coupled;GO:0042277~peptide binding;GO:0001653~peptide receptor activity	NA	hsa04610:Complement and coagulation cascades
KDM6B	GO:0006952~defense response;GO:0009611~response to wounding;GO:0006954~inflammatory response	NA	GO:0043565~sequence-specific DNA binding	NA	NA
CD9	GO:0009611~response to wounding;GO:0006928~cell motion;GO:0050817~coagulation;GO:0006873~cellular ion homeostasis;GO:0050801~ion homeostasis;GO:0007155~cell adhesion;GO:0019725~cellular homeostasis;GO:0007599~hemostasis;GO:0055082~cellular chemical homeostasis;GO:0048878~chemical homeostasis;GO:0050878~regulation of body fluid levels;GO:0042060~wound healing;GO:0008285~negative regulation of cell proliferation;GO:0042592~homeostatic process;GO:0034329~cell junction assembly;GO:0042127~regulation of cell proliferation;GO:0022610~biological adhesion;GO:0007596~blood coagulation	GO:0031982~vesicle;GO:0030141~secretory granule;GO:0005887~integral to plasma membrane;GO:0031410~cytoplasmic vesicle;GO:0044433~cytoplasmic vesicle part;GO:0031988~membrane-bounded vesicle;GO:0044459~plasma membrane part;GO:0031091~platelet alpha granule;GO:0031226~intrinsic to plasma membrane;GO:0005886~plasma membrane;GO:0016023~cytoplasmic membrane-bounded vesicle	NA	NA	hsa04640:Hematopoietic cell lineage
CR1	GO:0002443~leukocyte mediated immunity;GO:0002252~immune effector process;GO:0006955~immune response;GO:0009611~response to wounding;GO:0006959~humoral immune response;GO:0002250~adaptive immune response;GO:0006952~defense response;GO:0002526~acute inflammatory response;GO:0045087~innate immune response;GO:0002460~adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains;GO:0006954~inflammatory response;GO:0002684~positive regulation of immune system process	GO:0005886~plasma membrane;GO:0031226~intrinsic to plasma membrane;GO:0005887~integral to plasma membrane;GO:0044459~plasma membrane part	NA	IPR000436:Sushi/SCR/CCP;IPR016060:Complement control module	hsa04610:Complement and coagulation cascades;hsa04640:Hematopoietic cell lineage
NR4A1	GO:0010941~regulation of cell death;GO:0045944~positive regulation of transcription from RNA polymerase II promoter;GO:0043065~positive regulation of apoptosis;GO:0043067~regulation of programmed cell death;GO:0010942~positive regulation of cell death;GO:0042981~regulation of apoptosis;GO:0043068~positive regulation of programmed cell death	NA	GO:0046983~protein dimerization activity;GO:0003700~transcription factor activity;GO:0042803~protein homodimerization activity;GO:0043565~sequence-specific DNA binding	IPR003070:Orphan nuclear receptor	hsa04010:MAPK signaling pathway
LTBP4	GO:0040008~regulation of growth;GO:0001558~regulation of cell growth	GO:0031012~extracellular matrix;GO:0005578~proteinaceous extracellular matrix;GO:0005576~extracellular region;GO:0044421~extracellular region part	GO:0019955~cytokine binding;GO:0032403~protein complex binding;GO:0030246~carbohydrate binding;GO:0005539~glycosaminoglycan binding;GO:0030247~polysaccharide binding;GO:0005178~integrin binding;GO:0001871~pattern binding;GO:0019838~growth factor binding;GO:0005509~calcium ion binding	IPR018097:EGF-like calcium-binding, conserved site;IPR013032:EGF-like region, conserved site;IPR006210:EGF-like;IPR006209:EGF;IPR013091:EGF calcium-binding;IPR001881:EGF-like calcium-binding;IPR000742:EGF-like, type 3	NA
APOB	GO:0010033~response to organic substance;GO:0048514~blood vessel morphogenesis;GO:0048878~chemical homeostasis;GO:0051674~localization of cell;GO:0001944~vasculature development;GO:0034381~lipoprotein particle clearance;GO:0006928~cell motion;GO:0009791~post-embryonic development;GO:0034383~low-density lipoprotein particle clearance;GO:0042592~homeostatic process;GO:0045597~positive regulation of cell differentiation;GO:0051094~positive regulation of developmental process;GO:0001568~blood vessel development;GO:0048870~cell motility	GO:0034358~plasma lipoprotein particle;GO:0031982~vesicle;GO:0031410~cytoplasmic vesicle;GO:0044433~cytoplasmic vesicle part;GO:0031988~membrane-bounded vesicle;GO:0005576~extracellular region;GO:0031983~vesicle lumen;GO:0005615~extracellular space;GO:0005886~plasma membrane;GO:0044421~extracellular region part;GO:0016023~cytoplasmic membrane-bounded vesicle;GO:0032994~protein-lipid complex	GO:0030246~carbohydrate binding;GO:0046983~protein dimerization activity;GO:0005539~glycosaminoglycan binding;GO:0008201~heparin binding;GO:0030247~polysaccharide binding;GO:0001871~pattern binding	NA	NA
PRODH	GO:0008629~induction of apoptosis by intracellular signals;GO:0046394~carboxylic acid biosynthetic process;GO:0016053~organic acid biosynthetic process;GO:0042981~regulation of apoptosis;GO:0043068~positive regulation of programmed cell death;GO:0010941~regulation of cell death;GO:0043067~regulation of programmed cell death;GO:0043065~positive regulation of apoptosis;GO:0010942~positive regulation of cell death	NA	NA	NA	NA
STC1	GO:0006873~cellular ion homeostasis;GO:0055074~calcium ion homeostasis;GO:0006875~cellular metal ion homeostasis;GO:0006874~cellular calcium ion homeostasis;GO:0007584~response to nutrient;GO:0030003~cellular cation homeostasis;GO:0050801~ion homeostasis;GO:0055080~cation homeostasis;GO:0019725~cellular homeostasis;GO:0055082~cellular chemical homeostasis;GO:0055066~di-, tri-valent inorganic cation homeostasis;GO:0055065~metal ion homeostasis;GO:0030005~cellular di-, tri-valent inorganic cation homeostasis;GO:0048878~chemical homeostasis;GO:0001501~skeletal system development;GO:0031667~response to nutrient levels;GO:0042592~homeostatic process;GO:0009991~response to extracellular stimulus	GO:0005615~extracellular space;GO:0005576~extracellular region;GO:0044421~extracellular region part	NA	NA	NA
CHODL	GO:0007517~muscle organ development	NA	GO:0030246~carbohydrate binding;GO:0005539~glycosaminoglycan binding;GO:0005540~hyaluronic acid binding;GO:0030247~polysaccharide binding;GO:0001871~pattern binding	IPR018378:C-type lectin, conserved site;IPR001304:C-type lectin;IPR016186:C-type lectin-like	NA
FCAR	GO:0006955~immune response	GO:0005886~plasma membrane;GO:0031226~intrinsic to plasma membrane;GO:0005887~integral to plasma membrane;GO:0005576~extracellular region;GO:0044459~plasma membrane part	GO:0032403~protein complex binding	IPR013783:Immunoglobulin-like fold;IPR003599:Immunoglobulin subtype	NA
BATF3	NA	NA	GO:0046983~protein dimerization activity;GO:0003700~transcription factor activity;GO:0043565~sequence-specific DNA binding	IPR004827:Basic-leucine zipper (bZIP) transcription factor;IPR011616:bZIP transcription factor, bZIP-1;IPR000837:Fos transforming protein	NA
TTYH3	NA	GO:0005886~plasma membrane	GO:0005509~calcium ion binding	NA	NA
MFI2	GO:0050801~ion homeostasis;GO:0030003~cellular cation homeostasis;GO:0019725~cellular homeostasis;GO:0055080~cation homeostasis;GO:0055082~cellular chemical homeostasis;GO:0055066~di-, tri-valent inorganic cation homeostasis;GO:0048878~chemical homeostasis;GO:0030005~cellular di-, tri-valent inorganic cation homeostasis;GO:0006879~cellular iron ion homeostasis;GO:0042592~homeostatic process;GO:0006873~cellular ion homeostasis;GO:0055072~iron ion homeostasis;GO:0006826~iron ion transport	GO:0005886~plasma membrane;GO:0031226~intrinsic to plasma membrane;GO:0005887~integral to plasma membrane;GO:0005576~extracellular region;GO:0044459~plasma membrane part	NA	NA	NA
MIDN	NA	GO:0005730~nucleolus	NA	NA	NA
CDC42EP4	GO:0008360~regulation of cell shape;GO:0031344~regulation of cell projection organization;GO:0031346~positive regulation of cell projection organization;GO:0022604~regulation of cell morphogenesis	NA	NA	NA	NA
SMOC2	NA	GO:0031012~extracellular matrix;GO:0005578~proteinaceous extracellular matrix;GO:0005576~extracellular region;GO:0044421~extracellular region part	GO:0005509~calcium ion binding	NA	NA
DKK3	GO:0009968~negative regulation of signal transduction	GO:0005615~extracellular space;GO:0005576~extracellular region;GO:0044421~extracellular region part	NA	NA	NA
SPHK1	GO:0051270~regulation of cell motion;GO:0040017~positive regulation of locomotion;GO:0030334~regulation of cell migration;GO:0042981~regulation of apoptosis;GO:0051272~positive regulation of cell motion;GO:0051347~positive regulation of transferase activity;GO:0030335~positive regulation of cell migration;GO:0051174~regulation of phosphorus metabolic process;GO:0051338~regulation of transferase activity;GO:0008361~regulation of cell size;GO:0043067~regulation of programmed cell death;GO:0008284~positive regulation of cell proliferation;GO:0051726~regulation of cell cycle;GO:0030307~positive regulation of cell growth;GO:0043066~negative regulation of apoptosis;GO:0032535~regulation of cellular component size;GO:0051240~positive regulation of multicellular organismal process;GO:0060548~negative regulation of cell death;GO:0051094~positive regulation of developmental process;GO:0043069~negative regulation of programmed cell death;GO:0045859~regulation of protein kinase activity;GO:0042325~regulation of phosphorylation;GO:0045765~regulation of angiogenesis;GO:0045793~positive regulation of cell size;GO:0045860~positive regulation of protein kinase activity;GO:0043085~positive regulation of catalytic activity;GO:0048146~positive regulation of fibroblast proliferation;GO:0045787~positive regulation of cell cycle;GO:0045766~positive regulation of angiogenesis;GO:0019220~regulation of phosphate metabolic process;GO:0040012~regulation of locomotion;GO:0010941~regulation of cell death;GO:0040008~regulation of growth;GO:0001558~regulation of cell growth;GO:0044093~positive regulation of molecular function;GO:0043549~regulation of kinase activity;GO:0042127~regulation of cell proliferation;GO:0033674~positive regulation of kinase activity	GO:0005625~soluble fraction	NA	NA	NA
DEFB132	GO:0006952~defense response;GO:0009617~response to bacterium	GO:0005576~extracellular region	NA	NA	NA
OSMR	GO:0008284~positive regulation of cell proliferation;GO:0010033~response to organic substance;GO:0002675~positive regulation of acute inflammatory response;GO:0050727~regulation of inflammatory response;GO:0008283~cell proliferation;GO:0032103~positive regulation of response to external stimulus;GO:0034097~response to cytokine stimulus;GO:0032101~regulation of response to external stimulus;GO:0042127~regulation of cell proliferation	GO:0005886~plasma membrane;GO:0031226~intrinsic to plasma membrane;GO:0005887~integral to plasma membrane;GO:0044459~plasma membrane part	GO:0019955~cytokine binding;GO:0019838~growth factor binding	IPR008957:Fibronectin, type III-like fold;IPR003961:Fibronectin, type III	hsa04060:Cytokine-cytokine receptor interaction
XPNPEP2	NA	GO:0005886~plasma membrane	NA	NA	NA
TOP2A	GO:0012501~programmed cell death;GO:0042981~regulation of apoptosis;GO:0043068~positive regulation of programmed cell death;GO:0010941~regulation of cell death;GO:0030262~apoptotic nuclear changes;GO:0008219~cell death;GO:0006915~apoptosis;GO:0016265~death;GO:0043067~regulation of programmed cell death;GO:0043065~positive regulation of apoptosis;GO:0010942~positive regulation of cell death	GO:0005730~nucleolus	GO:0046983~protein dimerization activity;GO:0042803~protein homodimerization activity	NA	NA
SLC2A3	NA	GO:0005886~plasma membrane	NA	NA	NA
CYSLTR2	GO:0006955~immune response	GO:0005886~plasma membrane	NA	NA	NA
EDNRB	GO:0048246~macrophage chemotaxis;GO:0007626~locomotory behavior;GO:0060326~cell chemotaxis;GO:0042981~regulation of apoptosis;GO:0030595~leukocyte chemotaxis;GO:0051174~regulation of phosphorus metabolic process;GO:0006873~cellular ion homeostasis;GO:0043067~regulation of programmed cell death;GO:0006874~cellular calcium ion homeostasis;GO:0050801~ion homeostasis;GO:0030003~cellular cation homeostasis;GO:0019725~cellular homeostasis;GO:0055080~cation homeostasis;GO:0055065~metal ion homeostasis;GO:0055066~di-, tri-valent inorganic cation homeostasis;GO:0043066~negative regulation of apoptosis;GO:0030005~cellular di-, tri-valent inorganic cation homeostasis;GO:0003013~circulatory system process;GO:0042592~homeostatic process;GO:0060548~negative regulation of cell death;GO:0043069~negative regulation of programmed cell death;GO:0050900~leukocyte migration;GO:0042330~taxis;GO:0042325~regulation of phosphorylation;GO:0051674~localization of cell;GO:0006935~chemotaxis;GO:0006928~cell motion;GO:0043085~positive regulation of catalytic activity;GO:0048870~cell motility;GO:0006875~cellular metal ion homeostasis;GO:0055074~calcium ion homeostasis;GO:0008015~blood circulation;GO:0007204~elevation of cytosolic calcium ion concentration;GO:0055082~cellular chemical homeostasis;GO:0048878~chemical homeostasis;GO:0019220~regulation of phosphate metabolic process;GO:0016477~cell migration;GO:0010941~regulation of cell death;GO:0044093~positive regulation of molecular function;GO:0042127~regulation of cell proliferation	GO:0005886~plasma membrane;GO:0031226~intrinsic to plasma membrane;GO:0005887~integral to plasma membrane;GO:0044459~plasma membrane part	GO:0008528~peptide receptor activity, G-protein coupled;GO:0042277~peptide binding;GO:0001653~peptide receptor activity	NA	NA
GCLM	GO:0042981~regulation of apoptosis;GO:0006873~cellular ion homeostasis;GO:0043085~positive regulation of catalytic activity;GO:0043067~regulation of programmed cell death;GO:0050801~ion homeostasis;GO:0008015~blood circulation;GO:0019725~cellular homeostasis;GO:0055082~cellular chemical homeostasis;GO:0043066~negative regulation of apoptosis;GO:0048878~chemical homeostasis;GO:0010941~regulation of cell death;GO:0042493~response to drug;GO:0003013~circulatory system process;GO:0042592~homeostatic process;GO:0044093~positive regulation of molecular function;GO:0060548~negative regulation of cell death;GO:0043069~negative regulation of programmed cell death	GO:0005625~soluble fraction	GO:0046983~protein dimerization activity	NA	NA
BAG3	GO:0012501~programmed cell death;GO:0043066~negative regulation of apoptosis;GO:0042981~regulation of apoptosis;GO:0010941~regulation of cell death;GO:0008219~cell death;GO:0006915~apoptosis;GO:0016265~death;GO:0043067~regulation of programmed cell death;GO:0060548~negative regulation of cell death;GO:0043069~negative regulation of programmed cell death	NA	NA	NA	NA
CFB	GO:0007584~response to nutrient;GO:0010033~response to organic substance;GO:0002252~immune effector process;GO:0006955~immune response;GO:0009611~response to wounding;GO:0006959~humoral immune response;GO:0031667~response to nutrient levels;GO:0006952~defense response;GO:0002526~acute inflammatory response;GO:0045087~innate immune response;GO:0009991~response to extracellular stimulus;GO:0002684~positive regulation of immune system process;GO:0006954~inflammatory response	GO:0005886~plasma membrane;GO:0005576~extracellular region	NA	IPR000436:Sushi/SCR/CCP;IPR016060:Complement control module	hsa04610:Complement and coagulation cascades
PNP	GO:0008284~positive regulation of cell proliferation;GO:0042493~response to drug;GO:0050865~regulation of cell activation;GO:0050867~positive regulation of cell activation;GO:0045597~positive regulation of cell differentiation;GO:0006955~immune response;GO:0042127~regulation of cell proliferation;GO:0051094~positive regulation of developmental process;GO:0002684~positive regulation of immune system process	NA	GO:0016763~transferase activity, transferring pentosyl groups	NA	hsa00760:Nicotinate and nicotinamide metabolism
UPP1	NA	NA	GO:0016763~transferase activity, transferring pentosyl groups	NA	NA
IL4R	GO:0050865~regulation of cell activation;GO:0045596~negative regulation of cell differentiation;GO:0050867~positive regulation of cell activation;GO:0045597~positive regulation of cell differentiation;GO:0006955~immune response;GO:0051094~positive regulation of developmental process;GO:0002684~positive regulation of immune system process	GO:0005886~plasma membrane;GO:0031226~intrinsic to plasma membrane;GO:0005887~integral to plasma membrane;GO:0005576~extracellular region;GO:0044459~plasma membrane part	GO:0019955~cytokine binding;GO:0019838~growth factor binding	IPR008957:Fibronectin, type III-like fold;IPR003961:Fibronectin, type III	hsa04060:Cytokine-cytokine receptor interaction;hsa04640:Hematopoietic cell lineage
DUSP5	NA	NA	NA	NA	hsa04010:MAPK signaling pathway
DIAPH1	GO:0030036~actin cytoskeleton organization;GO:0030029~actin filament-based process;GO:0007010~cytoskeleton organization;GO:0007015~actin filament organization;GO:0051258~protein polymerization	GO:0005886~plasma membrane;GO:0044459~plasma membrane part	NA	NA	NA
